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Abstract 
Tissue engineering using adipose-derived stromal cells (ASCs) shows promise for soft tissue 
regeneration. Biodegradable polymers are potential biomaterials as they support the growth and 
delivery of cells. Specifically, poly(ester amide)s (PEAs) are a class of biodegradable polymers 
with tunable structures that have been shown to exhibit low cytotoxicity and support the growth 
of various cell types. This thesis involved the development of new water soluble amino acid-
based PEAs with crosslinkable moieties to enable formation of hydrogel scaffolds for ASC 
encapsulation. These hydrophilic phenylalanine-based and alanine-based PEAs were synthesized 
by solution polycondensation and photo-crosslinked into a series of hydrogels with and without 
poly(ethylene glycol) dimethacrylate, methacrylated chondroitin sulphate or decellularized 
adipose tissue, and hydrogel properties including gel content, equilibrium water content, and 
swelling were examined. ASC viability and adipogenesis were studied in selected PEA 
hydrogels, and the overall results demonstrated the potential of these new water soluble PEAs as 
biomaterials for adipose tissue engineering, as they provided a supportive environment for ASCs 
survival and adipogenic differentiation in culture.   
 
Keywords 
Adipose-derived stromal cells, biodegradable polymers, poly(ester amide)s, hydrogels, 
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Summary for Lay Audience 
Using cells to regenerate lost or damaged tissues is a promising alternative to current transplant 
approaches. In particular, adipose-derived stromal cells (ASCs), which can be isolated from 
waste fat tissue, are a special type of cells that can be converted into fat cells, and hold promise 
for fat regeneration for soft tissue reconstruction and cosmetic plastic surgery purposes. To aid in 
the delivery of these cells into the body and to support their growth, materials that are able to 
break down into nontoxic elements can be used to hold the cells. In this project, we have picked 
a class of materials called poly(ester amide)s (PEAs) that are capable of producing nontoxic 
components as they break down. The PEAs were made to be able to dissolve in water and to 
contain specific chemical features in order to form a hydrogel, which is a gel material that can 
take in a large amount of water and resembles the structure of soft tissues such as fat. ASCs were 
incorporated in these PEA hydrogels and observed for their behaviors inside the gels in terms of 
their survival and conversion to fat cells. However, using natural biological materials can often 
help with directing cell behaviors. Therefore, we added a material that has features similar to the 
environment of fat cells called decellularized adipose tissue (DAT) to the PEA hydrogels, which 
was also extracted from fat tissue. DAT was proposed to provide beneficial qualities to the 
overall hydrogels and better support the survival and fat cell conversion of the ASCs inside the 
gels. Based on the results, we found that the ASCs inside the hydrogels made from PEAs and 
PEAs with DAT survived well in culture and were able to convert into fat cells. As a result, the 
materials that we developed in this work showed potential to be used for fat regeneration.  
  
 iii 
 
Co-Authorship Statement  
The work described in this thesis is the result of a collaborative effort from the author, coworkers 
at Western University as well as supervisors Dr. Elizabeth Gillies and Dr. Lauren Flynn. The 
following details the individual contribution for each chapter.  
Chapter 1, the introduction was written by the author and revised by Dr. Elizabeth Gillies and 
Dr. Lauren Flynn.  
Chapter 2 describes a project proposed by Dr. Elizabeth Gillies and Dr. Lauren Flynn. All of the 
chemical synthesis and characterization experiments, hydrogel fabrication and characterization, 
cell isolation and culture setup, adipose tissue decellularization, cell encapsulation studies, cell 
viability and glycerol-3-phosphate dehydrogenase activity analyses as well as BODIPY staining 
were conducted by the author. Thermal data for the polymers was collected by Dr. Amir Rabiee 
Kenaree, a postdoctoral fellow in the Gillies lab, while the chromatographic runs were performed 
by Aneta Borecki, a technician in the Gillies lab. The chapter was written by the author and 
revised by Dr. Elizabeth Gillies and Dr. Lauren Flynn.      
Chapter 3, the conclusion was written by the author and revised by Dr. Elizabeth Gillies and Dr. 
Lauren Flynn.  
 iv 
 
Acknowledgments  
From the start, I would like to express my gratitude to my supervisors, Dr. Elizabeth Gillies and 
Dr. Lauren Flynn for their guidance and support. I have experienced many difficulties with my 
research project throughout the past two years, and your mentorship and encouragement have 
helped me get through every one of them.    
I would also like to thank all of the past and present members from both Gillies and Flynn labs, 
for providing a caring and cooperative environment. You have all made my graduate school 
journey very memorable. I especially want to thank Dr. Kai Cao and Dr. Arthi Shridhar for 
teaching me the technical skills and offering wonderful advices for my research. Additionally, a 
huge thank you to Charmainne Cruje and Nadia Sharma, from colleagues turning into lifetime 
friends. I will deeply treasure all of our memories inside and outside of the lab. I also want to 
show my gratitude to Megan, Thao and Jamie who are the amazing friends I have made in 
London.   
Thank you to my thesis examiners, Dr. James Wisner, Dr. Joe Gilroy and Dr. David O’Gorman 
for their time on reading my thesis.   
Last but not least, I want to express my wholehearted appreciation for my friends, my boyfriend, 
David and my dear family. This journey would not have been possible without their continuous 
love, support and encouragement.  
 v 
 
Table of Contents 
Abstract ............................................................................................................................................ i 
Summary for Lay Audience ............................................................................................................ ii 
Co-Authorship Statement ............................................................................................................... iii 
Acknowledgments .......................................................................................................................... iv 
Table of Contents ............................................................................................................................ v 
List of Tables ............................................................................................................................... viii 
List of Figures ................................................................................................................................ ix 
List of Schemes .............................................................................................................................. xi 
List of Appendices ........................................................................................................................ xii 
List of Abbreviations ................................................................................................................... xiii 
Chapter 1 ......................................................................................................................................... 1 
1 Introduction ................................................................................................................................ 1 
1.1 Biodegradable Polymers ..................................................................................................... 1 
1.1.1 Biopolymers ............................................................................................................ 1 
1.1.2 Synthetic Polymers ................................................................................................. 2 
1.2 Poly(ester amide)s ............................................................................................................... 4 
1.2.1 PEA Synthesis Methods .......................................................................................... 5 
1.2.2 Application of PEAs in Tissue Engineering ........................................................... 8 
1.3 Hydrogels in Biomedical Applications ............................................................................... 9 
1.3.1 Crosslinking Methods ............................................................................................. 9 
1.3.2 Hydrogel Design in Tissue Engineering ............................................................... 10 
1.4 Adipose Tissue Engineering ............................................................................................. 12 
1.4.1 Adipose-derived Stromal Cells ............................................................................. 12 
 vi 
 
1.5 Tissue Decellularization .................................................................................................... 14 
1.5.1 Adipose Tissue Decellularization ......................................................................... 15 
1.6 Project Motivation, Objective and Hypothesis ................................................................. 16 
1.6.1 Project Motivation ................................................................................................ 16 
1.6.2 Project Objective and Hypothesis ......................................................................... 17 
1.7 References ......................................................................................................................... 18 
Chapter 2 ....................................................................................................................................... 27 
2 Development of Poly(ester amide)-based Hydrogels for Adipose-derived Stromal Cell 
Encapsulation ........................................................................................................................... 27 
2.1 Introduction ....................................................................................................................... 27 
2.2 Experimental ..................................................................................................................... 29 
2.2.1 General Experimental Details ............................................................................... 29 
2.2.2 Synthesis of Monomers......................................................................................... 30 
2.2.3 Synthesis of Polymers ........................................................................................... 32 
2.2.4 Synthesis of Crosslinkers ...................................................................................... 34 
2.2.5 Human Adipose Tissue Procurement and Processing .......................................... 35 
2.2.6 Fabrication of Phe-PEA/Ala-PEA based Hybrid Hydrogels ................................ 37 
2.2.7 Characterization of the Hydrogel Properties ......................................................... 38 
2.2.8 hASC Photo-encapsulation and Culture within Phe-PEA/Ala-PEA based 
Hydrogels .............................................................................................................. 39 
2.2.9 Cell Viability ......................................................................................................... 39 
2.2.10 Glycerol-3-phosphate Dehydrogenase (GPDH) Activity ..................................... 40 
2.2.11 BODIPY Staining ................................................................................................. 40 
2.2.12 Statistical Analysis ................................................................................................ 41 
2.3 Results and Discussion ..................................................................................................... 41 
2.3.1 Synthesis and Characterization of Monomers ...................................................... 41 
 vii 
 
2.3.2 Synthesis and Characterization of Polymers ......................................................... 42 
2.3.3 Fabrication and Characterization of PEA-based Hydrogels ................................. 48 
2.3.4 Cell Viability ......................................................................................................... 52 
2.3.5 Glycerol-3-phosphate Dehydrogenase (GPDH) Activity ..................................... 55 
2.3.6 BODIPY Staining of Intracellular Lipid Accumulation ....................................... 57 
2.4 Conclusions ....................................................................................................................... 59 
2.5 References ......................................................................................................................... 60 
Chapter 3 ....................................................................................................................................... 64 
3 Conclusions and Future Work . ................................................................................................ 64 
3.1 References ......................................................................................................................... 66 
Appendix 1: Supplementary Figures ............................................................................................ 67 
Appendix 2: Research Ethics Board Approval ............................................................................. 77 
Curriculum Vitae .......................................................................................................................... 78 
 viii 
 
List of Tables  
Table 2.1. SEC and thermal analysis results for the two different PEAs. .................................... 44 
 
 ix 
 
List of Figures  
Figure 1.1. Chemical structures of a) collagen and b) chitosan. ..................................................... 2 
Figure 1.2. Chemical structures of a) poly(glycolic acid) and b) poly(lactic acid). ....................... 3 
Figure 1.3. Chemical structures of different types of PEAs ........................................................... 5 
Figure 1.4. Photo-crosslinking mechanism initiated by Irgacure 2959 ........................................ 10 
Figure 1.5. Chemical structure of Arg-PEA. ................................................................................ 11 
Figure 1.6. A schematic representation of ASC adipogenic differentiation. ................................ 13 
Figure 1.7. Schematic representation of photo-crosslinking of PEAs with the incorporation of 
DAT and ASC encapsulation. ....................................................................................................... 17 
Figure 2.1. Overlay of SEC traces of the two different PEAs in comparison to 2000 g/mol PEG.
....................................................................................................................................................... 44 
Figure 2.2. 1H NMR spectra of a) Phe-PEA and b) Ala-PEA in DMSO-d6 (400 MHz). ............. 45 
Figure 2.3. FT-IR spectra of a) Phe-PEA and b) Ala-PEA. .......................................................... 46 
Figure 2.4. TGA traces of Phe-PEA and Ala-PEA. ...................................................................... 47 
Figure 2.5. DSC traces of a) Phe-PEA and b) Ala-PEA. .............................................................. 47 
Figure 2.6. Chemical structures of a) PEGDMA and b) MCS. .................................................... 48 
Figure 2.7. Representative images of a series of hydrogel systems. ............................................. 49 
Figure 2.8. (a) Gel content of the hydrogels. (b) Equilibrium water content of the hydrogels. (c) 
Mass swelling ratio of the hydrogels. ........................................................................................... 50 
Figure 2.9. Compressive moduli of pure PEAs and PEAs + DAT systems. ................................ 51 
 x 
 
Figure 2.10. (a) ASC viability analysis of pure PEAs and PEAs + DAT systems at 24 h after 
encapsulation and at 7 days after induction of adipogenic differentiation. (b) Average number of 
viable ASCs per xy plane within the pure PEAs and PEAs + DAT systems. .............................. 53 
Figure 2.11. Representative images of ASCs encapsulated in Phe-PEA, Phe-PEA + DAT, Ala-
PEA and Ala-PEA + DAT hydrogel systems at 24 h: a) macroscopic view, and b) microscopic 
view. .............................................................................................................................................. 54 
Figure 2.12. GPDH activity of Phe-PEA, Phe-PEA + DAT, Ala-PEA and Ala-PEA + DAT 
hydrogel systems at 7 days after induction of adipogenic differentiation. ................................... 56 
Figure 2.13. Representative images of BODIPY-stained intracellular lipid droplets in ASCs 
encapsulated in Phe-PEA, Phe-PEA + DAT, Ala-PEA and Ala-PEA + DAT hydrogel systems at 
7 days after induction of adipogenic differentiation. .................................................................... 58 
 
 xi 
 
List of Schemes  
Scheme 1.1. Synthesis of amino acid-based PEAs by melt polycondensation ............................... 6 
Scheme 1.2. Synthesis of amino acid-based PEAs by solution polycondensation ......................... 7 
Scheme 1.3. Synthesis of amino acid-based PEAs by interfacial polymerization .......................... 8 
Scheme 2.1. Synthesis of a) di-p-toluenesulfonic acid salt monomers 1a-1c, b) di-p-nitrophenyl 
fumarate monomer 2 and c) PEG diamine macromonomer 3. ..................................................... 42 
Scheme 2.2. Synthesis of three different PEAs. ........................................................................... 43 
 
 xii 
 
List of Appendices  
Appendix 1: Supplementary Figures ............................................................................................ 67 
Appendix 2: Research Ethics Board Approval ............................................................................. 77 
 
 xiii 
 
List of Abbreviations 
ABAM Antibiotic-antimycotic 
Ala-PEA L-alanine based poly(ester amide) 
APS Ammonium persulphate 
Arg-PEA L-arginine based poly(ester amide) 
ASCs Adipose-derived stromal cells 
ATR Attenuated total reflectance 
BAAD Bis-a-(L-amino acid)-a, w-alkylene diester 
BAECs Bovine aortic endothelial cells 
BSA Bovine serum albumin 
C/EBPa/b/d CCAAT/enhancer binding protein-alpha/beta/delta 
CH2Cl2 Dichloromethane 
Đ Dispersity 
DAT Decellularized adipose tissue 
DMA N,N-dimethylacetamide 
DMAP 4-dimethylaminopyridine 
DMF N,N-dimethylformamide 
DSC Differential scanning calorimetry 
ECM Extracellular matrix 
EDTA Ethylenediaminetetraacetic acid 
Et3N Triethylamine 
EWC Equilibrium water content 
FABP4 Fatty acid binding protein-4 
FAS Fatty acid synthase 
 xiv 
 
FBS Fetal bovine serum 
FGF Fibroblast growth factor 
FT-IR Fourier-transform infrared 
GLUT4 Glucose transporter type-4 
GPDH Glycerol-3-phosphate dehydrogenase 
HCASMCs Human coronary artery smooth muscle cells 
IGF Insulin like growth factor 
LPL Lipoprotein lipase 
MCS Methacrylated chondroitin sulphate 
MMP Matrix metalloproteinase 
Mn Number average molar mass 
MSCs Mesenchymal stromal cells 
MWCO Molecular weight cutoff 
NMR Nuclear magnetic resonance 
p-TSA p-toluenesulfonic acid 
P4 Passage 4 
PBS Phosphate buffer saline 
PDLA Poly(D-lactic acid) 
PDLLA Poly(D,L-lactic acid) 
PEA Poly(ester amide) 
PEG Poly(ethylene glycol) 
PEGDMA PEG-dimethacrylate 
PGA Poly(glycolic acid) 
Phe-PEA L-phenylalanine based poly(ester amide) 
Phe8-PEA L-phenylalanine based poly(ester amide) with 1,8-octanediol  
 xv 
 
PLA Poly(lactic acid)  
PLGA Poly(lactic-co-glycolic) 
PLLA Poly(L-lactic acid) 
PMMA Poly(methyl methacrylate) 
PMSF Phenylmethylsulfonyl fluoride 
PPARg. Peroxisome proliferator-activated receptor-gamma 
ppm Parts per million 
PTFE Polytetrafluoroethylene 
RGD Arginine-glycine-aspartic acid  
RT-qPCR Real-time reverse transcription polymerase chain reaction 
SDS Sodium dodecyl sulphate 
SEC Size exclusion chromatography 
SPB Sorenson’s phosphate buffer 
TCPS Tissue culture polystyrene 
TEMED Tetramethylethylenediamine 
Tg Glass transition temperature 
TGA Thermogravimetric analysis 
Tm Melting temperature  
To Onset degradation temperatures 
UV Ultraviolet  
VEGF Vascular endothelial growth factor 
 
 
1 
 
Chapter 1  
1 Introduction 
1.1 Biodegradable Polymers 
In the past few decades, significant advancements have been made in the development of 
biomaterials to try to achieve better outcomes in their biomedical applications. Materials ranging 
from metals and ceramics to glasses and polymers have been explored for their potential as 
biomaterials.1,2 Polymers are one of the most promising classes of biomaterials due to their 
relative ease of chemical modification that provides a high diversity of physical and mechanical 
properties.1 Specifically, biodegradable polymers show great potential in the biomedical field, as 
these materials can be broken down and metabolized or excreted, eliminating the requirement for 
removal by surgical procedures if a temporary implant is required.1,2 This class of polymers can 
be degraded enzymatically or through non-enzymatic hydrolysis. Hydrolytically-degradable 
polymers contain specific chemical groups, such as anhydrides, esters, amides or ureas.3 
Enzymatically-degradable polymers often consist of naturally occurring monomers, such as 
amino acids, monosaccharides, glycolic acid or lactic acid.3 However, several factors need to be 
taken into consideration regarding the degradation of polymers, including their molar mass, 
hydrophilicity, crystallinity, and the pH of the surrounding medium.4 Biodegradable polymers 
can be developed from natural or synthetic polymers.  
1.1.1 Biopolymers 
Natural biodegradable polymers are referred to as biopolymers, such as collagen and chitosan, 
which are polymers formed by living organisms (Figure 1.1).5 Collagen is the most abundant 
protein found in the human body.6 It has a triple helical structure made from three polypeptide a 
chains, with each a chain composed of the repeating units of glycine-X-Y, where X and Y are 
commonly proline and 4-hydroxyproline, respectively.7 Collagen can be degraded enzymatically 
by matrix metalloproteinases (MMPs).8 Moreover, it has been reported to be used in a variety of 
biomedical applications, including as a scaffold in tissue engineering.1,6 For instance, collagen-
based scaffolds have been developed for skin engineering due to their ability to support cellular 
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adhesion and proliferation.9,10 In contrast, chitosan is the deacetylated derivative of chitin, found 
in the shells of arthropods, which has a structure of a linear polysaccharide composed of N-
glucosamine and N-acetyl-glucosamine.11 Chitosan can be degraded in vitro by a number of 
enzymes including chitosanase, lysozyme and papain, with lysozyme as the primary degrading 
enzyme in vivo.12,13 Furthermore, chitosan is capable of water absorption, oxygen permeability 
and facilitating haemostasis, the process of stopping bleeding; therefore it has been heavily 
investigated as a wound dressing material.14,15 However, biopolymers present limitations in 
terms of tuning their mechanical and chemical properties, whereas, synthetic polymers offer the 
advantage of property control as their structures can be more easily modified.  
 
 
 
 
 
 
 
 
 
Figure 1.1. Chemical structures of a) collagen and b) chitosan.  
1.1.2 Synthetic Polymers 
To design a biodegradable biomaterial suitable for biomedical applications, it should present the 
following properties: 1) not cause an inflammatory or toxic response, 2) have a degradation time 
matching with the requirements for the target application, 3) produce non-toxic degradation 
products that can be metabolized or excreted from the body, 4) possess suitable mechanical 
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properties for the intended applications, and 5) have suitable permeability and processability for 
the indicated application.16 A main challenge for developing such materials is the safety of the 
degradation products coming from the biodegradable polymers. This barrier has motivated 
interest in creating synthetic polymeric biomaterials such as poly(a-hydroxy acid)s and 
poly(amino acid)s, which are derived from natural metabolites in the human body.17  
In the context of biomaterials, poly(a-hydroxy acid)s have been extensively investigated. The 
commonly used poly(a-hydroxy acid)s in biomedical applications are poly(glycolic acid) (PGA) 
and poly(lactic acid) (PLA) (Figure 1.2).17 PGA has a high crystallinity of 45-55%, and thus 
exhibits a high Young’s modulus with low solubility in most organic solvents.18 It has a glass 
transition temperature (Tg) of 35-40 °C, which is defined as the temperature that the polymer 
changes from a hard, glassy material to a soft, rubbery material.19 It also has a high melting point 
(Tm) greater than 200 °C.19 Due to its favourable properties, PGA was utilized to develop the 
first biodegradable suture in 1969 under the trade name of DEXON®.20 On the other hand, the 
monomer of PLA is a chiral molecule and it polymerizes into four different morphological 
forms: poly(L-lactic acid) (PLLA), poly(D-lactic acid) (PDLA), the racemic poly(D,L-lactic acid) 
(PDLLA) and meso-PLA.21 However, among these four forms, only PLLA and PDLLA 
demonstrated potential in the biomedical field due to their properties.1 PLLA possesses a Tg of 
60-65 °C and a Tm of about 175 °C.18 It is a hard, crystalline polymer with a high Young’s 
modulus at approximately 4.8 GPa, which motivated its investigation in load bearing 
applications including orthopaedic fixation devices.18 Meanwhile, PDLLA, is an amorphous 
polymer that has a Tg of 55-60 °C with a lower Young’s modulus of about 1.9 GPa and a faster 
degradation rate than PLLA.19 These features have made it a better choice for drug delivery 
applications.22  
 
 
Figure 1.2. Chemical structures of a) poly(glycolic acid) and b) poly(lactic acid).  
Poly(amino acid)s are attractive candidates for biomedical applications due to their structural 
similarities with proteins. The use of amino acids offers properties including supporting cell-
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material interactions, the possibility to functionalize the pendant groups to allow for drug 
attachment, and enzymatic biodegradation leading to metabolically degradable building blocks.23 
Nevertheless, despite the biological advantages, many poly(amino acid)s have not been able to 
progress towards clinical applications due to their high crystallinities, low degradation rates, 
unfavourable mechanical properties, and immunogenicities.24 To translate the advantages of 
amino acids and to overcome the limitations of their polymer forms, amino acids have been 
integrated into the backbone of several types of polymers including poly(ester amide)s (PEAs) 
which will be discussed in detail below.23,25  
1.2 Poly(ester amide)s 
PEAs are a class of biodegradable polymers that can be prepared from a number of different 
monomer components, and they have been shown to exhibit suitable properties for a diverse 
range of biomedical applications.26-28 By definition, they are polymers containing ester and 
amide linkages that both contribute to biodegradability, while the amide linkages can provide 
enhanced mechanical and thermal properties relative to polyesters.26,27 Depending on the 
selection of monomers, different types of PEAs can be produced, such as polydesipeptides, 
copolymers consisting of a-hydroxy acids and a-amino acids; PEAs formed from diamide-diol, 
diester-diamine, diamide-diester and ester-diamine monomers with dicarboxylic acids 
derivatives or diols; and a-amino acid-based PEAs comprising a-amino acids, diols and 
dicarboxylic acids (Figure 1.3).26,27  In particular, a-amino acid-based PEAs have attracted much 
attention in the field of biomedical research. The incorporation of amino acids into the PEA 
backbone introduces favourable biological properties that are often lacking in synthetic 
polymers.23 In addition, the individual components of these PEAs offer flexibility in tuning their 
chemical, biological and mechanical properties as they can be easily modified to achieve 
properties required for different applications.26,28 
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Figure 1.3. Chemical structures of different types of PEAs: a) polydesipeptides and PEAs 
derived from monomers of b) diamide-diol, c) diester-diamine, d) diamide-diester and e) ester-
diamine, and f) amino acid-based PEAs.  
1.2.1 PEA Synthesis Methods 
PEAs derived from a-amino acids can be synthesized by melt polycondensation, solution 
polycondensation and interfacial polymerization. Melt polycondensation is a two-step reaction 
that first involves the formation of a diamide-diester under  mild conditions, followed by the 
reaction between the synthesized diamide-diester with a diol at a temperature over 200 °C with 
vacuum to favour the condensation process and to achieve a high molar mass polymer 
(Scheme 1.1).27,29 This procedure is considered to be advantageous for industrial production as 
polymer purification is typically not required.26 However, the disadvantages of this method 
include the required purification of diamide-diester, as well as the use of high reaction 
temperatures that can cause undesirable side reactions if the monomers are not pure or have 
functional side groups.26  
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Scheme 1.1. Synthesis of amino acid-based PEAs by melt polycondensation: a) formation of 
diamide-diester monomer and b) melt polycondensation between diamide-diester monomer 
and diol.  
Solution polycondensation, on the other hand, was developed to resolve the undesirable side 
reactions of melt polycondensation reactions and utilizes mild reaction conditions.26 This method 
is also known for generating high polymerization rates and high molar masses with minimal side 
reactions. There are three steps for this synthetic route (Scheme 1.2), including: 1) preparation of 
an activated ester from either dicarboxylic acids or diacyl chloride; 2) preparation of bis-a-(L-
amino acid)-a, w-alkylene diesters (BAAD) from a-amino acids and diols through Fischer 
esterification, in the presence of p-toluenesulfonic acid monohydrate (p-TSA), which catalyzes 
the reaction and protects the amino group as its salt; and 3) polymerization of the two prepared 
monomers at a temperature less than 80 °C.30 The drawbacks of this method include the 
requirements of pure monomers and careful control of stoichiometric balance in order to produce 
high molar mass PEAs, as well as the necessity to purify the polymer.23,31  
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Scheme 1.2. Synthesis of amino acid-based PEAs by solution polycondensation: a) formation of 
an activated ester monomer, b) formation of BAAD monomer and c) solution polycondensation 
between the activated ester monomer and BAAD monomer.  
While melt and solution polycondensations occur in a single phase, interfacial polymerization 
occurs at the interface of two immiscible phases that are typically water with an organic 
solvent.26 This method is a two-step reaction that involves the preparation of BAAD in the 
presence of p-TSA, and then the reaction of the synthesized monomer in the aqueous phase with 
a diacyl chloride in an organic solvent, often at room temperature to yield the desired polymer 
(Scheme 1.3).27 Typically, an inorganic base is used to neutralize the generated hydrogen 
chloride in order to prevent unwanted side reactions.32,33 Diacyl chlorides with long aliphatic or 
aromatic chains must be used to ensure their highly-preferential partitioning into the organic 
phase to avoid hydrolysis of the respective compound to its unreactive diacid form.32,33 Finally, 
the organic solvent must be carefully selected to allow for precipitation of the polymer at the 
targeting molar mass.32,33 Out of the three methods, solution polycondensation is the most 
commonly used synthetic route to prepare a-amino acids-based PEAs, as it favours high 
polymerization rates under mild conditions.27  
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Scheme 1.3. Synthesis of amino acid-based PEAs by interfacial polymerization: a) formation of 
BAAD monomer and b) interfacial polymerization between BAAD monomer and 
diacyl chloride.   
1.2.2 Application of PEAs in Tissue Engineering 
PEAs based on a-amino acids have been demonstrated by various research groups to exhibit low 
cytotoxicity.34–39 Given their biodegradability, they have become popular choices to be applied in 
tissue engineering. For instance, the Gillies and Mequanint groups have prepared a series of 
PEAs containing L-phenylalanine and L-alanine, as well as analogues of these PEAs with 
pendant functional groups through the incorporation of L-lysine by both solution and interfacial 
polymerizations.34 It was demonstrated that the PEAs were able to support human coronary 
artery smooth muscle cells (HCASMCs) attachment, spreading and proliferation, which makes 
them promising materials for vascular tissue engineering scaffolds. In a subsequent study, these 
amino acid-based PEAs were processed into ultrathin films that were shown to promote the 
formation of focal adhesions in HCASMCs seeded on the film surfaces.35 These findings 
indicated that these PEAs can promote integrin signalling, which is important for cell survival, 
migration and proliferation, and further expands their potential as scaffolds for vascular tissue 
engineering.  
Horwitz et al. synthesized PEAs deriving from L-lysine to provide pendant amines or L-aspartic 
acid to provide pendant carboxylic acids, and a neutral PEA (L-phenylalanine) and studied their 
ability to support bovine aortic endothelial cells (BAECs) viability, proliferation and adhesion, as 
well as their inflammatory response in vitro.36 It was found that all three forms of PEAs were 
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noncytotoxic and did not induce the activation of J774 mouse peritoneal macrophages. The 
results also demonstrated that the amino-functionalized PEA better supported BAECs adhesion, 
growth and monolayer formation as compared to the other two forms. These results suggested 
the potential of the PEAs to be used in tissue engineering as vascular grafts.  
Furthermore, Cui and coworkers have developed a copolymer of PEAs based on L-leucine and L-
glutamic acid with electroactive tetraaniline that had good electroactivity, mechanical properties 
and biodegradability.37 The study revealed that the tetraaniline-grafted PEAs were noncytotoxic 
and supported the adhesion and proliferation of mouse preosteoblastic MC3T3-E1 cells. These 
copolymers were also found to promote the differentiation of MC3T3-E1 cells when stimulated 
by pulsed electrical signal, which suggested their potential for application in vivo as a bone repair 
scaffold material in tissue engineering.    
1.3 Hydrogels in Biomedical Applications 
Hydrogels are defined as three-dimensional networks generated from hydrophilic polymers with 
the capability of absorbing large amounts of aqueous fluid.40 They have become attractive 
materials since the 1960 discovery made by Wichterle and Lim that poly(2-hydroxyethyl 
methacrylate)-based hydrogels could be used in soft contact lens.41 Since then, there has been an 
enormous growth in the use of hydrogels in biomedical applications including drug/gene 
delivery, wound healing and tissue engineering.42–45 For example, a hydrogel bead composed of 
N-succinyl chitosan/alginate has been reported for the controlled release of nifedipine.46 
Hydrogel dressings derived from both natural (e.g. gelatin or agar) and synthetic (e.g. 
polyacrylamide or polyvinylpyrrolidone) polymers have also been established to be used for 
wound care.47 Moreover, a number of biodegradable hydrogels have been found to support cell 
and tissue growth.48–50 Overall, there is great versatility in the design of hydrogels for a variety of 
applications, hence they play a vital role in the field of biomedical research.   
1.3.1 Crosslinking Methods 
Hydrogel networks can be generated through physical or chemical crosslinking mechanisms. 
Physically crosslinked hydrogels are formed by hydrogen bonding, hydrophobic interactions and 
ionic interactions.51–53 However, the network of these hydrogels can be disrupted due to their 
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relatively weak, non-covalent bonds.54 Covalently crosslinked hydrogels, on the other hand, 
typically exhibit the properties of stronger, more permanent networks.54 There are several 
approaches that can be used to form covalently crosslinked hydrogels, including 
photopolymerization, azide-alkyne cycloaddition and Diels-Alder cycloaddition.55–57 
Photopolymerization is one of the most widely used methods in biomedical applications due to 
the potential to have rapid formation of a crosslinked network at room temperature with spatial 
and temporal controls during the reaction process.58 Photopolymerization is initiated by light and 
requires the presence of unsaturated groups to undergo a free radical chain-growth 
polymerization when exposed to photo irradiation (Figure 1.4).59 Moreover, the formation of 
photo-crosslinked hydrogels often employs the use of photoinitiators (e.g. Irgacure 2959) to start 
polymerization with ultraviolet (UV) absorption ranging between 300-400 nm.59,60   
  
 
 
 
 
 
Figure 1.4. Photo-crosslinking mechanism initiated by Irgacure 2959: a) formation of radical 
from Irgacure 2959 upon UV absorption and initiating b) polymerization to form a crosslinked 
network.      
1.3.2 Hydrogel Design in Tissue Engineering 
Hydrogels are commonly used scaffolds for tissue engineering due to their high water content 
resembling that of soft tissues, highly tunable structures, high permeability to oxygen, nutrients 
and other water soluble metabolites, as well as their ability to allow for minimally invasive cell 
delivery at the target site.61,62 Hydrogel networks can derive from either natural or synthetic 
polymers. Natural polymers (e.g. collagen) possess desirable properties for tissue engineering, 
11 
 
including inherent biodegradability and bioactivity.61 Nevertheless, hydrogels derived from 
natural polymers can exhibit poor mechanical properties and can potentially cause immunogenic 
reactions.63,64 On the other hand, synthetic polymers offer the advantage of tailored properties 
due to their ease of structural modifications. For instance, the Chu group has developed water 
soluble cationic PEAs based on L-arginine (Arg) with varying methylene groups in the diol or 
diacid segment, and found that the difference in structures can influence the overall properties of 
the polymer (Figure 1.5).38 In a subsequent study, a hybrid hydrogel was generated through 
photo-crosslinking of the Arg-PEA with poloxamer (a triblock copolymer consisting of one 
poly(propylene oxide) and two poly(ethylene glycol)) diacrylate to investigate if the addition of 
Arg-PEA improved cellular interactions as compared to the pure poloxymer hydrogel.39 The 
study showed that the hybrid hydrogel enhanced the attachment and proliferation of Detroit 539 
human fibroblast cells, as well as the viability of encapsulated BAECs, indicating that the 
introduction of Arg-PEA positively influenced the cell behavior within the system. Unlike 
natural polymers, synthetic polymers can also provide more reproducible physical and chemical 
properties, which is important for scaffold fabrication in tissue engineering.61  
 
 
 
 
Figure 1.5. Chemical structure of Arg-PEA.  
Although property tunability from synthetic hydrogels is a desirable characteristic, they present a 
major limitation as tissue-engineering scaffolds, which is the lack of biological cues. To improve 
their biological properties, bioactive molecules have been used to modify synthetic hydrogels to 
mediate cell functions.65–67 The incorporation of bioactive molecules into the hydrogel network 
can enhance the biological function of the scaffold, as it mimics the extracellular matrix 
environment for supporting cell growth.61,63 Stile and Healy have developed a peptide-modified 
hydrogel system from poly(N-isopropylacrylamide) containing the Arg-Gly-Asp (RGD) peptide 
sequence.68 Their study demonstrated that the peptide-modified hydrogel better supported the 
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proliferation of encapsulated rat calvarial osteoblasts than the unmodified hydrogel. Ultimately, 
the development of a hybrid hydrogel scaffold containing both biological and synthetic materials 
is a promising approach for tissue engineering.  
1.4 Adipose Tissue Engineering 
The currently available methods to restore soft tissue loss caused by disease or injury are 
autologous fat transplantation and implantable fillers, but they often result in complications 
including donor site morbidity and volume loss of the injected fat tissue.69 To address these 
issues, the development of adipose tissue engineering serves as a potential strategy for 
reconstructive and cosmetic plastic surgery in replacing lost or damaged soft tissue within the 
subcutaneous layer.70,71 This method employs a three-dimensional biomaterial scaffold 
embedded with regenerative cell populations, such as adipose-derived stromal cells (ASCs), that 
provides a microenvironment composed of biological signals to support cell growth leading to 
tissue formation.72  
1.4.1 Adipose-derived Stromal Cells 
ASCs, identified in 2001, are defined as mesenchymal stromal cells (MSCs) found in the adipose 
tissue that can be differentiated into adipogenic (fat), chondrogenic (cartilage) and osteogenic 
(bone) lineages in culture.73 Their abundance and accessibility are very advantageous for 
research in tissue engineering, as they can be collected from various sites including breast and 
abdomen through lipo-suction or lipo-reduction procedures in which the tissues are usually 
discarded as waste.73–75 Upon processing, one gram of adipose tissue can yield up to 500-fold 
more MSCs than bone marrow aspirate.76 In addition, ASCs display immunomodulatory 
properties, promote angiogenesis, the process of forming new blood vessels, and secrete growth 
factors that stimulate the recruitment and differentiation of tissue resident cells that can 
contribute to tissue regeneration.77,78  The differentiation of ASCs is directly related to the 
culturing conditions containing selective lineage-specific induction factors.73 Here, we will focus 
the adipogenic differentiation of ASCs, which is described in the next section.  
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1.4.1.1 Adipogenesis 
Adipogenesis is promoted when ASCs are seeded at high cell density that eventually leads to 
growth arrest.79 This initial growth arrest can be stimulated by the addition of pro-differentiative 
hormones and cytokines in vitro, along with triggering the signaling cascade of adipogenic 
differentiation (Figure 1.6).80 The main transcriptional regulators involved in this differentiation 
process are members of the CCAAT/enhancer binding protein (C/EBP) and peroxisome 
proliferator-activated receptor (PPAR) families.79,81,82 This process starts with the activation of 
early transcription factors, C/EBPb and C/EBPd in pre-adipocytes, followed by the stimulation 
of the principal transcription factors of adipogenesis which are C/EBPa and PPARg.79,81,82 These 
two transcription factors work together to maintain a positive feedback loop, while C/EBPa also 
works to maintain growth arrest as well as to inhibit ASCs proliferation. As the process leads to 
the terminal differentiation stage, the formation of adipocytes is observed and can be 
characterized by the expression of adipogenic genes including lipoprotein lipase (LPL), glycerol-
3-phosphate dehydrogenase (GPDH), glucose transporter type-4 (GLUT4), fatty acid synthase 
(FAS), fatty acid binding protein-4 (FABP4), insulin receptor, malic enzyme and acetyl CoA 
carboxylase.   
 
 
 
Figure 1.6. A schematic representation of ASC adipogenic differentiation.  
1.4.1.2 Scaffolds for Adipose Tissue Engineering 
Both natural and synthetic polymers have been used as scaffolds for adipose tissue engineering. 
A variety of implantable scaffolds have been developed from different polymers and exhibited 
positive responses in supporting the adipogenic differentiation of seeded ASCs.83–86 For 
example, Itoi et al. have demonstrated the potential of collagen as a scaffold for adipogenesis, 
with fat formation observed in ASC-seeded collagen sponges at 8 weeks after subcutaneous 
implantation in nude mice.83 Moreover, another group prepared a scaffold from poly(lactic-co-
14 
 
glycolic) acid (PLGA) and showed that the scaffold promoted the differentiation of seeded ASCs 
into adipocytes 5 weeks after implantation in Lewis rats.84      
Hydrogels are also commonly used as scaffolds for adipose tissue engineering and can offer the 
advantage that they can be injected at the defect site through minimally invasive means, followed 
by in situ crosslinking, thus minimizing the risks of infections and scarring from implantation.72 
For instance, Patel et al. have found that poly(ethylene glycol) (PEG)-based hydrogels modified 
with peptides improved ASC adhesion and proliferation as compared to a system with no 
peptides.87 Uriel et al. have investigated the potential of adipose protein-derived hydrogels to 
induce adipogenesis, and observed higher adipose levels than for MatrigelTM, a commercially 
available basement membranes-based product extracted from mouse sarcoma, both in vitro and 
in vivo.88 Based on these studies, the design of a composite hydrogel incorporating bioactive 
molecules that supports cell survival and promotes the differentiation of progenitor cells towards 
the adipogenic lineage holds potential as a strategy to enhance fat formation for tissue 
engineering applications.  
1.5 Tissue Decellularization 
The extracellular matrix (ECM) is a complex and dynamic environment containing proteins and 
polysaccharides.89,90 It is crucial in mediating cellular functions including adhesion, migration, 
viability, proliferation and differentiation. Therefore, cell behavior is highly dependent on the 
ECM environment, as it not only provides structural support, but also presents the biochemical 
and biomechanical signals that are important mediators of cellular activities. Moreover, the 
composition and organization of the ECM is tissue-specific, as the environment is different from 
one tissue to another. As described in the earlier section, the design of tissue-engineering 
scaffolds with integrated bioactive moieties to mimic the properties of the natural ECM may 
direct cellular functions, leading to tissue formation.61 Numerous studies have been conducted 
with the utilization of ECM-derived molecules such as collagen, laminin or fibronectin for the 
design of bio-scaffolds.91–93 However, these systems do not replicate the complexity of the native 
ECM. As a result, tissue decellularization to isolate tissue-specific ECM using approaches that 
strive to preserve the structural architecture and biochemical composition of the ECM while 
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removing cellular contents has emerged as a promising approach for the development of cell 
delivery vehicles for tissue regeneration.94,95      
1.5.1 Adipose Tissue Decellularization 
A variety of decellularized ECMs have been prepared from different tissue types, including 
adipose tissue, dermis and bone.96–98 Specifically, decellularized adipose tissue (DAT) has been 
studied extensively as a biomaterial for adipose tissue regeneration, which can be applied to 
restore soft tissue loss within the subcutaneous layer.99 Upon decellularization, a number of vital 
proteins and polysaccharides are conserved in the resulting DAT. Components that provide the 
integrity, structure and function of adipose tissue found in DAT include structural proteins such 
as collagen types I-VI, adhesive glycoproteins such as laminin and fibronectin, 
glycosaminoglycans and proteoglycans.100 A number of growth factors are also found in the 
DAT that are associated with regulating adipocyte differentiation, angiogenesis and homeostasis 
upon stimulation including fibroblast growth factor 2 (FGF2), insulin like growth factor 1 (IGF1) 
and vascular endothelial growth factor (VEGF).100        
DAT is obtained after a decellularization procedure involving a series of physical, chemical and 
enzymatic treatments. Particularly, the Flynn lab has developed a novel detergent-free method 
for adipose tissue decellularization that successfully preserves the essential elements of the 
adipose tissue ECM.96 Within the protocol, physical treatments employ the use of freeze-thaw 
cycles for lysing the cells, and the combination of hydrostatic pressure with hypotonic solutions 
to further break down the cells.96,101 The chemical treatments involve the use of isopropanol 
washes to remove lipids from the adipose tissue, while the enzymatic steps utilize trypsin, a 
serine protease, and ethylenediaminetetraacetic acid (EDTA), a chelating agent that disrupts cell-
cell and cell-ECM binding, along with the use of nucleases (DNase and RNase) to cleave nucleic 
acids.96,101 There are other groups that have reported the use of detergents such as sodium 
dodecyl sulphate (SDS) and Triton X-100 in their adipose decellularization protocols to extract 
cellular contents.102,103 However, a concern associated with the use of detergent is the potential 
cytotoxicity resulting from residual detergents remaining within the tissues, in which is not an 
issue for the detergent-free protocol.104   
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As the development of decellularized ECM bio-scaffolds has become an attractive approach for 
regenerative research, several studies have demonstrated the instructive effects of DAT on the 
lineage-specific differentiation of ASCs. For example, the Flynn group has shown that DAT-
derived scaffolds, microcarriers and foams provide an inductive effect by promoting the 
adipogenic differentiation of ASCs both in vitro and in vivo.96,105–107 Wang and coworkers also 
found that the injection of DAT-based microparticles containing ASCs into an engineered fat 
graft implanted in a Fischer rat model promoted fat formation at 8 weeks.103 In addition, further 
processing of the DAT into micronized particles allows the ECM to be incorporated into 
hydrogel carriers.108,109 The Flynn lab has previously demonstrated that composite hydrogels 
derived from methacrylated chondroitin sulphate (MCS) with incorporated DAT particles 
enhanced the adipogenic differentiation of encapsulated ASCs relative to MCS controls.108,109 
Overall, these findings show the promising role of decellularized tissue-specific ECM in stem 
cell differentiation and ultimately, in tissue regeneration.  
1.6 Project Motivation, Objective and Hypothesis 
1.6.1 Project Motivation 
PEAs have been studied for their potential in biomedical applications including tissue 
engineering due to their biodegradability and the ease of tuning their structure and properties.26–
28 However, only a few examples of PEA hydrogels for cell encapsulation have been reported 
due to the challenges of obtaining water soluble PEAs.38,39,110,111 These PEAs are cationic and 
difficult to reproducibly synthesize based on past experience in our lab. Moreover, although it 
has been demonstrated that PEAs exhibit low cytotoxicity and support various cell types, the 
behavior of ASCs in PEA systems has not yet been investigated. Given the potential cell-
instructive properties of DAT and its ability to be incorporated into hydrogels when processed 
into particles, here we propose the design of hybrid hydrogels based on PEAs and DAT that will 
offer the structural control of synthetic polymers and the biological cues of natural materials to 
support and control the differentiation of ASCs.    
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1.6.2 Project Objective and Hypothesis 
The goals of this thesis were to develop water soluble PEAs with crosslinkable moieties for the 
fabrication of hydrogel carriers for ASC encapsulation, and to study the potential of the PEA 
systems with and without DAT as a cell-instructive scaffolds for ASC delivery for applications 
in adipose tissue engineering.  
The hypothesis for this project is that PEAs derived from L-phenylalanine and L-alanine will 
support the viability of encapsulated ASCs and the incorporation of DAT into the PEA hydrogels 
will enhance cell viability and adipogenic differentiation in culture.  
Chapter 2 describes the detailed procedures for the development of hydrophilic PEAs, followed 
by hydrogel fabrication using these PEAs through photo-crosslinking. After the hydrogels were 
characterized, DAT particles were incorporated into these polymeric scaffold systems and their 
properties were studied. In addition, human ASCs were encapsulated into the PEA systems with 
and without DAT incorporation (Figure 1.7), and ASC viability and adipogenic differentiation 
within these scaffolds were studied.      
  
 
 
 
 
Figure 1.7. Schematic representation of photo-crosslinking of PEAs with the incorporation of 
DAT and ASC encapsulation.   
Chapter 3 summarizes the key results obtained from the previous chapter and discusses the future 
directions of this project.   
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Chapter 2  
2 Development of Poly(ester amide)-based Hydrogels for 
Adipose-derived Stromal Cell Encapsulation 
2.1 Introduction 
The development of biodegradable polymers as biomaterials has become an attractive approach 
in the biomedical field. While the chemical flexibility of polymers allows researchers to create 
materials with a wide range of properties, biodegradable polymers provide the additional 
advantage of being able to be broken down and absorbed or excreted, eliminating the need for 
removal by surgical procedures.1,2 However, the design of biodegradable biomaterials comes 
with many challenges, as the materials should possess a number of essential properties required 
for biomedical applications.3 Firstly, the material should be nontoxic and should not cause a 
negative host response. Secondly, the material should be tailored to degrade once its function is 
complete and the degradation products should be nontoxic. Next, the material should have 
mechanical properties tuned for the targeted application. Finally, the material should also have 
the appropriate permeability and processability for the intended use.    
Poly(ester amide)s (PEAs) are a class of biodegradable polymers containing ester and amide 
linkages in their backbones. They often possess properties of both polyesters and polyamides, 
including the biodegradability of polyesters and high mechanical strength and thermal stability of 
polyamides.4,5 Specifically, PEAs derived from amino acids, diols and dicarboxylic acids serve 
as promising materials for biomedical applications. The incorporation of amino acids into the 
PEA backbone introduces favorable biological properties, such as supporting cell-material 
interactions, and enzymatic biodegradation leading to metabolizable building blocks.6 As the 
properties of these polymers can be easily tailored by chemical modifications, a number of 
amino acid-based PEAs have been developed to be applied in a variety of applications.4,5,7 For 
instance, the Gillies and Mequanint groups demonstrated that PEAs containing L-phenylalanine, 
L-alanine and L-lysine were able to support human coronary artery smooth muscle cell 
attachment, spreading and proliferation, making them promising materials for vascular tissue 
engineering scaffolds.8 del Valle et al. studied the controlled release of ibuprofen from PEAs 
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based on L-alanine, sebacic acid and 1,12-dodecanodiol.9 In addition, the Chu group has 
developed a water soluble PEA formulation from cationic L-arginine that has been explored for 
applications including gene delivery and wound healing.10–13 To the best of our knowledge, this 
is the only reported water soluble, amino acid-based PEA reported to date. Hence, further 
research on the development of water soluble PEAs is warranted to expand our knowledge on 
their material properties and explore their applications for cell delivery and tissue engineering.   
Tissue engineering for tissue regeneration and treating diseases aims to regenerate damaged 
tissues using scaffold biomaterials in combination with cells.14 However, the lack of cell delivery 
platforms that ensure the retention, survival and maintenance of cellular function over the longer 
term remains a significant challenge.14,15 Hydrogels are commonly used as scaffolds for tissue 
engineering due to their high water content resembling that of soft tissue, structural tunability, 
high permeability to oxygen, nutrients and other water soluble metabolites, and in some cases 
their ability to allow for minimally-invasive cell delivery at the target site.16,17  
In recent years, the use of bioactive molecules in the design of hydrogels has gained attention 
with the focus on improving the biological function of the scaffolds.16 Hydrogels derived from 
synthetic polymers lack the biological cues to guide the behavior of encapsulated cells, and the 
addition of bioactive molecules can help to mimic the extracellular matrix (ECM) environment 
and mediate cellular functions.16,18 However, the ECM is a highly complex and dynamic 
environment containing a diverse array of extracellular macromolecules, and it is a significant 
challenge to mimic the complexity of the native ECM environment through the incorporation of 
bioactive molecules within the scaffold.19–22 A promising alternative approach is to incorporate 
decellularized tissue-specific ECM into synthetic scaffold systems as it has been reported to 
enhance cell viability and help to direct cell function.23,24 Specifically, the Flynn group  and 
others have demonstrated that biomaterials derived from decellularized adipose tissue (DAT) can 
enhance the viability of adipose-derived stem cells (ASCs) and promote the adipogenic 
differentiation of ASCs both in vitro and in vivo.25–30 These findings show great promise for the 
role of decellularized tissue-specific ECM in stem cell differentiation and ultimately, in tissue 
regeneration.  
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Here we proposed the development of a new water soluble PEA with crosslinkable moieties to 
enable in situ gelation for hydrogel formation and cell encapsulation. The water solubility was 
achieved by the incorporation of poly(ethylene glycol) (PEG) blocks into the L-phenylalanine-
based and L-alanine-based PEAs at a specific molar ratio. The properties of the hydrogels 
fabricated from pure PEAs, as well as those synthesized with crosslinker groups or DAT 
particles were studied. The potential of these PEA systems as biomaterials for adipose tissue 
regeneration was investigated by evaluating ASC attachment and viability following 
encapsulation within the scaffolds, along with determining whether the PEAs-based scaffolds 
supported the differentiation of ASCs towards the adipogenic lineage both with and without 
DAT incorporation. 
2.2 Experimental 
2.2.1 General Experimental Details 
Poly(ethylene glycol) (2000 g/mol) and p-nitrophenol were purchased from Alfa Aesar 
(Haverhill, MA, USA). L-Alanine, 4-dimethylaminopyridine (DMAP) and p-toluenesulfonyl 
chloride were purchased from AK Scientific Inc. (Union City, CA, USA). Chondroitin sulphate 
(50,000 g/mol) was purchased from LKT Laboratories (St. Paul, MN, USA). NH4OH and 
MgSO4 were purchased from Caledon Laboratories (Georgetown, ON, Canada). Toluene was 
distilled over sodium and benzophenone under nitrogen at atmospheric pressure to remove water 
before use. Triethylamine (Et3N), dichloromethane (CH2Cl2) and N,N-dimethylacetamide 
(DMA) were distilled over calcium hydride under nitrogen at atmospheric pressure to remove 
water before use. All other chemicals were purchased from Sigma Aldrich (St. Louis, MO, 
USA). All solvents and chemicals were used as received unless otherwise noted.  
Dialysis was performed using Spectra/Por 6 dialysis tubing from Spectrum Laboratories (Rancho 
Dominguez, CA, USA) with molecular weight cutoff (MWCO) of 10 kg/mol or 3.5 kg/mol. Size 
exclusion chromatography (SEC) was performed using an instrument equipped with a Waters 
515 HPLC pump, a Waters In-Line Degasser AF, two PLgel mixed D 5µm (300 x 1.5 mm) 
columns connected to a corresponding PLgel guard column, and a Wyatt Optilab Rex RI detector 
operating at 658 nm. Samples were dissolved in N,N-dimethylformamide (DMF) containing 
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10 mM LiBr and 1% v/v Et3N at a concentration of ~5 mg/mL. Each sample was filtered through 
a 0.22 µm polytetrafluoroethylene (PTFE) syringe filter prior to injection using a 50 µL loop. 
Samples were run at a flow rate of 1 mL/min for 30 min at 85 °C. Molar mass calibrations were 
carried out using poly(methyl methacrylate) (PMMA) standards. Thermogravimetric analysis 
(TGA) was performed on a TA Q50 instrument with a heating rate of 10 °C/min up to a 
maximum temperature of 1000 °C under nitrogen. Differential scanning calorimetry (DSC) was 
performed on a TA Q2000 instrument with a heating/cooling rate of 10 °C/min under nitrogen. 
Tm was obtained from the second heating cycle.  1H and 13C nuclear magnetic resonance (NMR) 
spectra were recorded on either a 400 HMz Bruker AvIII HD instrument or a 600 MHz Varian 
INOVA instrument in CDCl3, D2O or DMSO-d6.  Chemical shifts are reported in parts per 
million (ppm) with the solvent signals as reference. Fourier-transform infrared (FT-IR) spectra 
were obtained using a PerkinElmer FT-IR Spectrum Two instrument with attenuated total 
reflectance (ATR) sampling.  
2.2.2 Synthesis of Monomers 
2.2.2.1 Synthesis of di-p-toluenesulfonic acid salt monomer, 1a 
The compound was synthesized as previously reported.31 A suspension of L-phenylalanine (12 g, 
73 mmol, 2.2 equiv.) with p-toluenesulfonic acid  monohydrate (15 g, 79 mmol, 2.4 equiv.) in 
dry toluene (120 mL) was refluxed and stirred at 130 °C in a flask equipped with a Dean-Stark 
trap for 2 h to remove the residual water. 1,4-butanediol (2.9 mL, 33 mmol, 1.0 equiv.) was then 
added to the solution and refluxed for 48 h. The resulting material was filtered and recrystallized 
from water (300 mL) following its hot filtration. The product was then collected by vacuum 
filtration and dried in vacuo to yield a light yellow powder. Yield: 60%. 1H NMR (600 MHz, 
DMSO-d6): δ 8.40 (br s, 5H), 7.48 (d, 4H, J = 7.4 Hz), 7.33-7.23 (m, 10H), 7.12 (d, 4H, J = 7.8), 
4.30 (t, 2H, J = 6.9), 3.99 (s, 4H), 3.15-3.00 (m, 4H), 2.29 (s, 6H), 1.39-1.28 (m, 4H). Spectral 
data agreed with those previously reported.   
2.2.2.2 Synthesis of di-p-toluenesulfonic acid salt monomer, 1b 
The compound was synthesized as previously reported.31 A suspension of L-phenylalanine (5.0 
g, 30 mmol, 2.2 equiv.) with p-toluenesulfonic acid monohydrate (6.8 g, 36 mmol, 2.4 equiv.) in 
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dry toluene (110 mL) was refluxed and stirred at 130 °C in a flask equipped with a Dean-Stark 
trap for 2 h to remove the residual water. 1,8-octanediol (2.0 g, 15 mmol, 1.0 equiv.) was then 
added to the solution and refluxed for 48 h. The resulting material was filtered and recrystallized 
from water (100 mL) following its hot filtration. The product was then collected by vacuum 
filtration and dried in vacuo to yield a white powder. Yield: 70%. 1H NMR (600 MHz, DMSO-
d6): δ 8.43 (br, s, 4H), 7.50 (d, 4H, J = 7.9 Hz), 7.34-7.20 (m, 10H), 7.13 (d, 4H, J = 8.2 Hz), 
4.25 (dd, 2H, J1 = 7.7 Hz, J2 = 6.1 Hz), 4.04-3.98 (m, 4H), 3.16-2.98 (m, 5H), 2.28 (s, 6H), 1.44-
1.37 (m, 4H), 1.17-1.05 (m, 8H). Spectral data agreed with those previously reported.   
2.2.2.3 Synthesis of di-p-toluenesulfonic acid salt monomer, 1c 
The compound was synthesized as previously reported.31 A suspension of L-alanine (5.0 g, 57 
mmol, 2.2 equiv.) with p-toluenesulfonic acid monohydrate (11 g, 62 mmol, 2.4 equiv.) in dry 
toluene (100 mL) was refluxed and stirred at 130 °C in a flask equipped with a Dean-Stark trap 
for 2 h to remove the residual water. 1,8-octanediol (3.7 g, 26 mmol, 1.0 equiv.) was then added 
to the solution and refluxed for 48 h. The resulting material was filtered and recrystallized from 
isopropanol (30 mL) following its hot filtration. The product was then collected by vacuum 
filtration and dried in vacuo to yield a white powder. Yield: 68%. 1H NMR (600 MHz, DMSO-
d6): δ 8.27 (br s, 6H), 7.49 (d, 4H, J = 8.1 Hz), 7.12 (d, 4H, J = 7.8 Hz ), 4.19-4.08 (m, 6H), 2.29 
(s, 6H), 1.62-1.58 (m, 4H), 1.38 (d, 6H, J = 7.2 Hz), 1.34-1.26 (m, 8H). Spectral data agreed with 
those previously reported.   
2.2.2.4 Synthesis of di-p-nitrophenyl fumarate monomer, 2 
The compound was synthesized as previously reported.32 A solution of p-nitrophenol (8.3 g, 60 
mmol, 2.0 equiv.) and Et3N (8.4 mL, 60 mmol, 2.0 equiv.) in acetone (100 mL) was cooled to -
78 °C using a dry ice/acetone bath. Fumaryl chloride (3.2 mL, 30 mmol, 1.0 equiv.) in acetone 
(40 mL) was added dropwise over a period of 2 h. The reaction mixture was then allowed to 
reach room temperature and stirred overnight. The resulting solution was precipitated in water 
(800 mL), and then filtered, washed and dried under high vacuum. The crude product was then 
purified by recrystallizing in acetonitrile (400 mL) to yield a white solid. Yield: 60%. 1H NMR 
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(600 MHz, DMSO-d6): δ 8.37 (d, 4H, J = 9.1 Hz), 7.60 (d, 4H, J = 9.1 Hz), 7.27 (s, 2H). Spectral 
data agreed with those previously reported.   
2.2.2.5 Synthesis of PEG ditosylate 
PEG (2000 g/mol, 40 g, 40 mmol, 1.0 equiv.) was dried in vacuo with P2O5 at 80 °C overnight 
before dissolving in CH2Cl2 (150 mL). Et3N (25 mL, 180 mmol, 4.5 equiv.) and DMAP (2.4 g, 
20 mmol, 0.5 equiv.) were added to the solution, and then it was cooled to 0 °C upon addition of 
p-toluenesulfonyl chloride (34 g, 180 mmol, 4.5 equiv.). The reaction mixture was then allowed 
to reach room temperature and stirred overnight. The resulting solution was filtered to remove 
salts. It was then washed with 1 M HCl (2 x 40 mL) and the collected aqueous layer was washed 
with CH2Cl2 (2 x 100 mL). The combined organic layer was dried over magnesium sulphate 
(MgSO4), concentrated and precipitated in cold ethyl ether (400 mL). The product was then 
collected by vacuum filtration and dried in vacuo to yield a white, tacky solid. Yield: 75%. 1H 
NMR (600 MHz, CDCl3): δ 7.81 (d, 4H, J = 8.3 Hz), 7.35 (d, 4H, J = 8.0 Hz), 4.16 (t, 4H, J = 4.2 
Hz), 3.65 (s, 177H), 2.45 (s, 6H). Spectral data agreed with those previously reported.33   
2.2.2.6 Synthesis of PEG diamine macromonomer, 3 
PEG ditosylate (30 g, 13 mmol, 1 equiv.) was added to ammonium hydroxide (105 mL, 
790 mmol, 61 equiv.), and the solution was stirred at room temperature for 5 days. The solution 
was then washed with CH2Cl2 (5 x 100 mL). The organic layer was dried over MgSO4, 
concentrated and precipitated in cold diethyl ether (300 mL). The product was then collected by 
vacuum filtration and dried in vacuo to yield a white powder. Yield: 84%. 1H NMR (600 MHz, 
CDCl3): δ 3.65 (s, 172H), 3.53 (t, 4H, J = 5.2 Hz), 2.88 (t, 3H, 5.2 Hz). Spectral data agreed with 
those previously reported.33   
2.2.3 Synthesis of Polymers 
2.2.3.1 Synthesis of Phe-PEA 
Monomer 1a (0.30 g, 0.42 mmol, 0.30 equiv.), monomer 2 (0.50 g, 1.4 mmol, 1.0 equiv.) and 
macromonomer 3 (2.0 g, 0.98 mmol, 0.70 equiv.) were dissolved with stirring in dry DMA (8.0 
mL) at 60 °C. Et3N (0.43 mL, 3.1 mmol, 2.2 equiv.) was added dropwise to the solution, and 
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then it was stirred at 70 °C for 6 h. The resulting solution was concentrated, re-dissolved in 
CH2Cl2 and precipitated in cold diethyl ether (250 mL). The crude product was purified by 
dialysis against DMF (500 mL) for 48 h using a 10 kg/mol MWCO membrane. The solution was 
then concentrated, re-dissolved in CH2Cl2 and precipitated in cold diethyl ether (250 mL). The 
product was centrifuged, the liquid decanted, and then the solid was dried in vacuo to yield a 
white solid. Yield: 70%. 1H NMR (400 MHz, DMSO-d6): δ 8.92-8.87 (m, 0.69H), 8.50-8.46 (m, 
1.64H), 7.30-7.19 (m, 4.29H), 6.86-6.83 (m, 2.00H), 4.58-4.52 (m, 0.78H), 3.98 (s, 1.44H), 3.70-
3.66 (m, 1.46H), 3.51 (s, 190H) 3.07-2.89 (m, 2.92H) 1.45 (s, 1.48H). 13C NMR (100 MHz, 
DMSO-d6): δ 171.3, 163.8, 163.6, 136.9, 132.6, 131.8, 129.0, 128.3, 126.6, 69.8, 69.6, 68.9, 
53.9, 36.8, 24.4. FT-IR: 3510, 3295, 2879, 1739, 1641, 1547 cm-1. SEC: Mn = 19.9 kg/mol, Mw = 
49.2 kg/mol, Đ = 2.46, Tm = 36 °C. 
2.2.3.2 Synthesis of Phe8-PEA 
Monomer 1b (0.066 g, 0.084 mmol, 0.30 equiv.), monomer 2 (0.10 g, 0.28 mmol, 1.0 equiv.) and 
macromonomer 3 (0.40 g, 0.19 mmol, 0.70 equiv.) were dissolved with stirring in dry DMA (2.0 
mL) at 60 °C. Et3N (0.10 mL, 0.61 mmol, 2.2 equiv.) was added dropwise to the solution, and 
then it was stirred at 70 °C for 6 h. The resulting solution was concentrated, re-dissolved in 
CH2Cl2 and precipitated in cold diethyl ether (100 mL). The crude product was purified by 
dialysis against DMF (200 mL) for 48 h using a 10 kg/mol MWCO membrane. The solution was 
then concentrated, re-dissolved in CH2Cl2 and precipitated in cold diethyl ether (100 mL). The 
product was centrifuged, the liquid decanted, and then the solid was dried in vacuo to yield a 
white solid. Yield: 58%. 1H NMR (400 MHz, DMSO-d6): δ 8.89-8.85 (m, 0.69H), 8.50-8.45 (m, 
1.58H), 7.29-7.18 (m, 4.23H), 6.85-6.82 (m, 2.00H), 4.56-4.51 (m, 0.66H), 4.00-3.97 (m, 
1.36H), 3.69-3.67 (m, 1.25H), 3.51 (s, 187H), 3.07-2.89 (m, 2.70H), 1.46 (s, 1.49H), 1.19 (s, 
3.61H). 13C NMR (100 MHz, DMSO-d6): δ 163.8, 163.6, 136.9, 133.3, 132.6, 129.0, 128.2, 
126.6, 69.8, 69.6, 68.9, 64.6, 54.9, 53.9, 36.7, 28.5. 27.9, 25.2. FT-IR: 3522, 3298, 2881, 1733, 
1632, 1547 cm-1. SEC: Mn = 20.1 kg/mol, Mw = 56.6 kg/mol, Đ = 2.81, Tm = 37°C. 
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2.2.3.3 Synthesis of Ala-PEA 
Monomer 1c (0.26 g, 0.42 mmol, 0.30 equiv.), monomer 2 (0.50 g, 1.4 mmol, 1.0 equiv.) and 
macromonomer 3 (2.0 g, 0.98 mmol, 0.70 equiv.) were dissolved with stirring in dry DMA (8.0 
mL) at 60 °C. Et3N (0.43 mL, 3.1 mmol, 2.2 equiv.) was added dropwise to the solution, and 
then it was stirred at 70 °C for 6 h. The resulting solution was concentrated, re-dissolved in 
CH2Cl2 and precipitated in cold diethyl ether (250 mL). The crude product was purified by 
dialysis against DMF (500 mL) for 48 h using a 10 kg/mol MWCO membrane. The solution was 
then concentrated, re-dissolved in CH2Cl2 and precipitated in cold diethyl ether (250 mL). The 
product was centrifuged, the liquid decanted, and then the solid was dried in vacuo to yield a 
white solid. Yield: 77%. 1H NMR (400 MHz, DMSO-d6): δ 8.82-8.78 (m, 0.59H), 8.51-8.45 (m, 
1.46H), 6.89-6.83 (m, 2.00H), 4.34-4.29 (m, 0.64H), 4.08-3.97 (m, 1.41H), 3.71-3.65 (m, 
1.98H), 3.51 (s, 177H), 1.54 (s, 1.41H), 1.31-1.22 (m, 5.12H). 13C NMR (100 MHz, DMSO-d6): 
δ 172.3, 163.8, 132.6, 69.8, 69.6, 68.9, 64.4, 47.9, 28.5, 28.0, 25.2, 16.9. FT-IR: 3521, 3296, 
2880, 1737, 1639, 1546 cm-1. SEC: Mn = 18.9 kg/mol, Mw = 56.1 kg/mol, Đ = 2.96, Tm = 34 °C. 
2.2.4 Synthesis of Crosslinkers 
2.2.4.1 Synthesis of PEG-dimethylacrylate 
The synthesis of PEG-dimethylacrylate was modified from a previously reported procedure.34 
PEG (2000 g/mol, 10 g, 10 mmol, 1.0 equiv.), triethylamine (7 mL, 50 mmol, 5.0 equiv.) and 
DMAP (0.3 g, 2.5 mmol, 0.25 equiv.) were dissolved in CH2Cl2 (20 mL). The solution was then 
cooled to 0 °C and methacryloyl chloride (5.2 g, 50 mmol, 5.0 equiv.) in CH2Cl2 (10 mL) was 
added dropwise over a period of 30 min. The reaction mixture was then allowed to reach room 
temperature and stirred overnight. The resulting solution was filtered to remove salts. It was then 
washed with water (10 mL) and the combined aqueous layers were washed with CH2Cl2 (2 x 20 
mL). The combined organic layers were dried over MgSO4, concentrated, and precipitated in 
cold diethyl ether (150 mL). The product was then collected by vacuum filtration and dried in 
vacuo to yield a white, tacky solid. Yield: 57%. 1H NMR (600 MHz, CDCl3): δ 6.12 (s, 2H), 
5.57 (s, 2H), 4.45-4.25 (m, 4H), 3.76-3.73 (m, 4H), 3.64 (s, 193H), 1.94 (s, 6H). FT-IR: 2881, 
1717 cm-1. Spectral data agreed with those previously reported. 
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2.2.4.2 Synthesis of Methacrylated Chondroitin Sulphate 
The compound was prepared as previously reported.35 Chondroitin sulphate (0.20 g) was added 
to 0.1 M sodium phosphate monobasic buffer (1.0 mL) and dissolved with stirring. Then, 6 M of 
NaOH was carefully added to adjust the solution to ~pH 10 before addition of methacrylic 
anhydride (60 µL). The reaction was stirred for 1 h at room temperature with constant pH 
adjustment to maintain a pH of ~10. The resulting solution was then precipitated in ethanol (10 
mL). The product was filtered and purified through dialysis against water (2 L) in 3.5 kg/mol 
MWCO membrane for 48 h. The final solution was lyophilized for 48 h to yield a white solid. 1H 
NMR (600 MHz, D2O): 6.19 and 5.75 ppm are the two protons attached to the double bond, and 
1.95 ppm is the methyl protons adjacent to double bond. Percentage of methacrylation 
determined from 1H NMR was 17%. Spectral data agreed with those previously reported.  
2.2.5 Human Adipose Tissue Procurement and Processing 
Adipose tissue samples were obtained from female patients undergoing elective lipo-reduction 
surgeries involving the breast or abdomen at the University Hospital and St. Joseph’s Health 
Care Hospital in London, ON, Canada (HREB 105426). Within 2 h of extraction, the samples 
were transported to the lab on ice in sterile phosphate buffer saline (PBS) supplemented with 20 
mg/mL bovine serum albumin (BSA), and processed for ASC isolation or decellularization using 
previously reported methods, as described below.25,36  
2.2.5.1 Human Adipose-derived Stromal Cell Culture 
Human ASCs were isolated from adipose tissue samples within 2 h of procurement using 
previously published methods.36 The tissue samples were first minced using surgical scissors, 
and then added to collagenase digest solution composed of 2 mg/mL collagenase type II 
(Worthington Biochemical, Lakewood, NJ), 25 mM HEPES (Bioshop Inc., Burlington, ON), 3 
mM glucose and 20 mg/mL BSA in Kreb’s Ringer bicarbonate buffer (pH 7.4) to undergo 
agitation (100 rpm) for 45 min at 37 °C. Next, undigested tissue segments were removed by 
filtering the sample through a 250 µm stainless steel filter. The collected filtrate was allowed to 
gravity sediment for 5 min to form two layers. The upper layer of adipocytes was removed by 
aspiration and left with the fraction containing the adipose precursor cells within the stromal 
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vascular cell population. Then, an equal volume of proliferation medium comprised of 
DMEM:Ham’s F-12 medium supplemented with 10% fetal bovine serum (FBS; Thermo 
Scientific Hyclone, Cat. # SH30396) and 100 U/mL penicillin and 0.1 mg/mL streptomycin (1% 
pen-strep) was added to the samples to inactivate the collagenase. The samples were centrifuged 
(1200 xg, 5 min, 25 °C) and resuspended in erythrocyte lysing buffer composed of 0.154 M 
NH4Cl, 0.1 mM EDTA and 10 mM KHCO3 in sterile deionized water. The sample suspension 
was agitated for 10 min at room temperature. Following agitation, the cells were centrifuged 
again and resuspended in proliferation medium before filtering through a 100 µm nylon filter 
(Corning Inc., Corning, NY). Finally, the cells were plated in tissue culture flasks (Corning Inc., 
Corning, NY) and incubated for 24 h at 37 °C with 5% CO2, followed by PBS rinses to remove 
any non-adherent cells or fragments. Fresh proliferation medium was provided every 2-3 days. 
When the cells reached 80% confluence, they were passaged using 0.25% trypsin/0.1% EDTA 
(Gibco®, Invitrogen, Burlington, ON) and re-plated in new flasks at 6,000-7,000 cells/cm2. 
Passage 4 (P4) ASCs were used for all cell encapsulation studies, and each study was repeated 
with three different donors (N = 3). The summary of cell donor information used for each 
biological study is listed in the Appendix (Table A1).   
2.2.5.2 Adipose Tissue Decellularization 
Adipose tissue samples were decellularized following an established detergent-free protocol.25 
The decellularization solution volume used in this procedure was based on the ratio of 50 g of 
tissue per 100 mL of solution. The collected tissue samples were first transferred into hypotonic 
10 mM Tris-EDTA buffer (pH 8.0) supplemented with 1% (v/v) antibiotic-antimycotic (ABAM; 
Gibco®, Invitrogen, Burlington, ON) and 0.27 mM phenylmethylsulfonyl fluoride (PMSF), and 
then frozen at -80 °C. Next, the tissue samples were thawed at 37 °C under agitation (120 rpm). 
This was repeated two more times for a total of three freeze-thaw cycles. Following the last 
freeze-thaw cycle, the tissues were added to enzymatic digestion solution #1 comprised of 0.25% 
trypsin/0.1% EDTA with 1% ABAM and incubated overnight. Then the samples were subjected 
to polar solvent extraction for 48 h to remove the lipid content, by transferring into absolute 
isopropanol supplemented with 1% ABAM and 0.27 mM PMSF. Subsequently, the samples 
were rinsed three times (30 min each) in Sorenson’s phosphate buffer (SPB; pH 8.0) solution 
composed of 8 g/L NaCl, 200 mg/L KCl, 1 g/L Na2HPO4 and 200 mg/L KH2PO4 with 1% 
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ABAM before 6 h incubation in enzymatic digestion solution #1. Repeated three 30 min rinses in 
SPB solution was applied to the samples, and then they were incubated overnight in enzymatic 
digestion solution #2 containing 55 mM Na2HPO4, 17 mM KH2PO4, 4.9 mM MgSO4•7H2O, 
15,000 U DNase Type II (from bovine pancreas), 12.5 mg RNase Type III A (from bovine 
pancreas) and 2000 U lipase Type VI-S (from porcine pancreas) with 1% ABAM. The next day, 
the samples were rinsed three times (30 min each) in SPB solution, subjected to a final polar 
solvent extraction for 8 h, and rinsed three times (30 min each) again in SPB solution. The 
resulting DAT was then rinsed three times (30 min each) in 70% ethanol followed by repeated 
rinses in sterile deionized water. Finally, the DAT was frozen at -80 °C and lyophilized prior to 
further processing.  
2.2.5.3 Cryo-milling of Decellularized Adipose Tissue 
DAT was pooled from three different donors before cryo-milling using previously established 
protocols.28 The collected DAT particles were stored at 4 °C until further use. Prior to hydrogel 
fabrication, the DAT particles were decontaminated in 70% ethanol overnight, and then were 
rinsed three times consecutively for 1 h in PBS.  
2.2.6 Fabrication of Phe-PEA/Ala-PEA based Hybrid Hydrogels 
Pure (Phe-PEA and Ala-PEA alone) and hybrid (Phe-PEA/Ala-PEA + PEGDMA/MCS) 
hydrogels were fabricated without ASCs for physical characterization studies. All hydrogels 
were made with a prepolymer solution concentration of 10% (m/v) in PBS. For the hybrid 
hydrogels, the prepolymer solutions contained 7.5% (m/v) of Phe-PEA or Ala-PEA and 2.5% 
(m/v) of PEGDMA or MCS. The photoinitiator, 2-hydroxy-4’-(2-hydroxyethoxy)-2-
methylpropiophenone (Irgacure 2959) was added last to the solution at a concentration of 0.15% 
(m/v). The prepolymer solution was then transferred to a 1 mL syringe (Thermo Scientific, 
Waltham, MA, USA), and photo-crosslinked with long-wavelength ultraviolet light (365 nm) at 
an intensity of 16 mW/cm2 for 4 min (2 min on each side of the syringe). Pure Phe-PEA and Ala-
PEA hydrogels were also prepared with the incorporation of DAT particles. Milled DAT 
particles were added to the prepolymer solutions at a concentration of 2% (m/v) and the 
crosslinking was performed as described above.     
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2.2.7 Characterization of the Hydrogel Properties  
2.2.7.1 Gel Content and Equilibrium Water Content 
Gel content and equilibrium water content (EWC) were measured in cell-free hydrogels (n = 3) 
using methods adapted from a previously established source.37 After photo-crosslinking, the 
initial mass (mi) of each hydrogel was recorded and the theoretical mass (mt) of polymers 
involved in crosslinking was calculated as mi x 0.1. The hydrogels were swollen in PBS for 24 h, 
and the swollen mass (ms) was recorded to determine the EWC. Then, the hydrogels were rinsed 
three times successively in distilled water for 3 h to remove remaining non-crosslinked materials 
and salts from PBS. Following the rinses, the hydrogels were frozen in liquid nitrogen, 
lyophilized, and their dry masses (md) were measured. The gel content and EWC were calculated 
using equations (1) and (2):  
Gel	content = 	*+*, 	x	100%                              (1) 
EWC = 	*45	*+*4 	x	100%                               (2) 
2.2.7.2 Mass Swelling Ratio  
Mass swelling ratio was measured (n = 3) using previously reported methods.38 After the 
hydrogels were prepared, their masses (mi) were recorded. The hydrogels were then swollen to 
equilibrium in PBS at 37 °C, and the swollen mass was recorded (ms). The mass swelling ratio 
was calculated according to the following equation:  
Mass	swelling	ratio = 	*45	*=*= 	x	100%           (3) 
2.2.7.3 Compression Testing 
Samples (n = 3) were prepared in 1 mL syringes as described above. Before compression testing, 
the dimensions of the swollen cylindrical hydrogels were recorded using calipers, with each 
sample having a height to width ratio of ~2. Unconfined stress-strain measurements were 
conducted using a UniVert system (CellScale, Waterloo, ON, Canada), equipped with a 0.5 N 
load cell. During the measurement, the samples were immersed in a 37 °C PBS bath, preloaded 
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at 0.01 N at every cycle, and compressed to a total strain of 20% at a rate of 0.6%/s. The nominal 
stress was calculated by dividing the applied force by the initial cross-sectional area of the 
sample. The compressive modulus was determined from the slope of the linear region of the 
stress-strain curve between 10 and 15% strain.  
2.2.8 hASC Photo-encapsulation and Culture within Phe-PEA/Ala-PEA 
based Hydrogels  
The prepolymer solutions of Phe-PEA, Phe-PEA + DAT, Ala-PEA and Ala-PEA + DAT systems 
were prepared as described in Section 2.2.6. ASCs were encapsulated within the hydrogels at P4 
through suspension in proliferation medium at a concentration of 1 x 107 cells/mL. The final 
solution volume contained 80% prepolymer and 20% ASC suspension by volume was then 
photo-crosslinked by the methods described above. Immediately after crosslinking, the hydrogels 
were cut into 25 µL in size, each containing ~2.5 x 105 cells, transferred into 12-well inserts 
(Greiner Bio-one, Germany), and cultured in proliferation medium at 37 °C with 5% CO2. After 
24 h, the hydrogels were changed into serum-free adipogenic differentiation medium to induce 
differentiation. The adipogenic differentiation medium contained the following supplements: 
DMEM:Ham’s F-12 nutrient mixture, 1% pen-strep, 33 µM biotin, 17 µM pantothenate, 10 
µg/mL transferrin, 100 nM hydrocortisone, 66 nM insulin, and 1 nM triiodothyronine, with 0.25 
mM isobutylmethylxanthine and 1 µg/mL troglitazone incorporated into the differentiation 
medium for the first 72 h.39 Fresh medium was provided to all samples every 2-3 days.     
2.2.9 Cell Viability  
Viability of the encapsulated ASCs in the Phe-PEA-based and Ala-PEA-based hydrogels with 
0% and 2% DAT was assessed at 24 h after encapsulation and at 7 days after the induction of 
adipogenic differentiation (n = 3, N = 3) using the LIVE/DEAD® Viability/Cytotoxicity Kit for 
mammalian cells (Life Technologies Inc., Burlington, ON, Canada). DAT particles could be 
detected by confocal microscopy due to autofluorescence. During the preparation, the hydrogels 
were rinsed twice in PBS before incubation in the staining solution comprised of 2 µM calcein 
AM and 4 µM ethidium homodimer-1 for 45 min at 37 °C. Then, the hydrogels were rinsed two 
times with PBS before imaging utilizing a Zeiss Multiphoton LSM 510 META confocal 
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microscope (ZEISS, Canada). Images were captured at 10X magnification, and a mosaic stitch 
technique was used to capture the complete cross-sectional area of the hydrogel. For each 
sample, a total of 5 layers were collected, and each layer was separated by 75 µm. Image J 
analysis software was used to quantify the number of live and dead cells in each layer in order to 
calculate the average cell viability for each group.  
2.2.10 Glycerol-3-phosphate Dehydrogenase (GPDH) Activity  
Quantitative assessment of ASC adipogenesis was conducted by measuring intracellular GPDH 
enzyme activity in the Phe-PEA-based and Ala-PEA-based hydrogels with 0% and 2% DAT 
hydrogels at 7 days after adipogenic induction (n = 3, N = 3) using a GPDH Enzyme Activity 
Measurement Kit (Kamiya Biomedical Corporation, Cat. # KT-010, Seattle, WA, USA). 
Moreover, ASCs cultured on tissue culture polystyrene (TCPS) 6-well plates in proliferation 
medium (negative control) and adipogenic differentiation medium (positive control) were 
included in the study. During the preparation, the hydrogels were rinsed three times in PBS, 
followed by the addition of 500 µL of enzyme extracting reagent (pH 7.4) provided with the kit. 
The hydrogels were then broken into smaller pieces by crushing them using a plastic pestle. The 
crushed samples were lysed using an ultrasonic homogenizer (Model-100, Fisher Scientific), and 
centrifuged (12,800 xg, 5 min, 4 °C) to isolate the cytosolic fraction containing the intracellular 
GPDH enzyme. To normalize the GPDH activity levels, the total cytosolic protein content for all 
samples was measured using the Pierce 660 Protein Assay Kit (Thermo Scientific, Waltham, 
MA, USA) with an albumin standard. Immediately, the samples were measured for total protein 
content and GPDH activity using a CLARIOstar® spectrophotometer (BMG Labtech, Ortenberg, 
Germany). One unit of GPDH activity was defined as the activity required to oxidize 1 µM of 
NADH in 1 min.  
2.2.11 BODIPY Staining  
Qualitative assessment of ASC adipogenesis was performed using BODIPY® 493/503 staining 
(Thermo Scientific, Waltham, MA, USA) to capture intracellular lipid accumulation in the ASCs 
encapsulated in the Phe-PEA-based and Ala-PEA-based hydrogels with 0% and 2% DAT 
hydrogels at 7 days after adipogenic induction (n = 3, N = 3). As mentioned earlier, DAT 
41 
 
particles could be visualized due to autofluorescence. The BODIPY® stock solution was 
prepared in DMSO at 1 mg/mL, and diluted in PBS by a factor of 1:500. The hydrogels were 
rinsed two times in PBS and then incubated in the staining solution at 37 °C for 1 h. Following 
incubation, the hydrogels were rinsed twice in PBS before imaging utilizing a Zeiss Multiphoton 
LSM 510 META confocal microscope, with images collected at 25X magnification using a water 
immersion objective.  
2.2.12 Statistical Analysis 
Data are reported as the mean ± standard deviation (SD), and the statistical analyses were 
performed using GraphPad Prism 6 (GraphPad Software, San Diego, CA, USA) by one-way or 
two-way ANOVA with a Tukey’s post-hoc test. Differences were considered statistically 
significant at p < 0.05.  
2.3 Results and Discussion 
2.3.1 Synthesis and Characterization of Monomers  
The monomers used to prepare the PEAs were synthesized as previously reported 
(Scheme 2.1).31,32 The original goal was to synthesize a series of PEAs that differed by the length 
of diol component (4 carbons vs 8 carbons) and the type of amino acid (phenylalanine vs 
alanine), and to explore the effects on the properties from their structural differences. However, 
the synthesis of di-p-toluenesulfonic acid salt monomer deriving from L-alanine and 1,4-
butanediol resulted in very low yield, hence only the polymerization from the other three 
monomers 1a-c were further pursued. Di-p-nitrophenyl fumarate, monomer 2 was synthesized to 
provide the crosslinkable component of PEAs due to its double bond. Additionally, since L-
alanine and L-phenylalanine are naturally hydrophobic, hydrophilic poly(ethylene glycol) (PEG) 
diamine, macromonomer 3 was incorporated to introduce water solubility to the polymer. All 
monomers were characterized by 1H NMR spectroscopy and the spectral data matched with the 
literature values (Figures A1-A6).31–33   
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Scheme 2.1. Synthesis of a) di-p-toluenesulfonic acid salt monomers 1a-1c, b) di-p-nitrophenyl 
fumarate monomer 2 and c) PEG diamine macromonomer 3.  
2.3.2 Synthesis and Characterization of Polymers  
The polymers are named by the abbreviations of the three letter amino acid designation from 
monomer 1: Phe-PEA, Phe8-PEA (phenylalanine monomer with 8 carbons in the diol segment) 
and Ala-PEA. All polymerization reactions were carried out in optimized solution co-
polycondensation conditions that were derived from a procedure reported previously 
(Scheme 2.2).32 The challenges that were involved during the process of polymerization included 
finding the molar ratio of monomer 1 and  macromonomer 3 required to produce water soluble 
PEAs, and the determination of a reaction time to prevent the crosslinking between the 
monomers as the previously-reported 48 h reaction time for the previous PEAs resulted in the 
formation of insoluble gel-like materials. The crosslinking could possibly occur by Michael 
addition between the amine groups of monomer 1 or macromonomer 3 with the double bond of 
monomer 2 or through a free radical mechanism.  
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Scheme 2.2. Synthesis of three different PEAs.   
Water solubility of PEAs was achieved by varying the amounts of monomer 1 and 
macromonomer 3. Three different ratios of the two monomers were examined: 50:50, 40:60 and 
30:70 of monomers 1:3. It was found that 0.7 molar equivalent of macromonomer 3 was the 
minimum amount required to achieve water solubility of the polymer for Phe-PEA and Ala-PEA. 
However, Phe8-PEA was not water soluble for any of the prepared ratios, and was therefore 
excluded from further studies. In addition, after conducting a kinetic study of this polymerization 
reaction, it was found that a 6 h reaction time yielded no formation of insoluble materials with 
reproducible molar mass achievable for the resulting polymers. Overall, the best of the evaluated 
conditions for the PEA synthesis were: molar ratio of the three monomers (1:2:3) equal to 
0.3:1.0:0.7, 70 °C reaction temperature, 6 h reaction time with dry N,N-dimethylacetamide 
(DMA) as the solvent and triethylamine (Et3N) as the base.  
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The polymers were characterized by 1H NMR spectroscopy, 13C NMR spectroscopy, FT-IR 
spectroscopy, SEC, TGA and DSC. The number average molar mass (Mn) and dispersity (Đ) 
data were obtained from SEC analysis using refractive index detection and were determined 
relative to PMMA standards (Table 2.1). Both Phe-PEA and Ala-PEA had Mn values close to 20 
kg/mol and Đ of 2.46 and 2.96 respectively. The SEC data indicated that polymerization had 
occurred between the monomers as the elution time for PEAs were much shorter than for the 
starting 2000 g/mol PEG (Figure 2.1). The Đ values were relatively high for solution 
polycondensation, which might be attributed to a small amount of crosslinking. However, as the 
PEAs were designed to be incorporated in subsequent steps into a network, this was not 
problematic.      
Table 2.1. SEC and thermal analysis results for the two different PEAs.   
Type of PEAs Mn (kg/mol) Đ To (°C) Tm (°C) 
Phe-PEA 19.9 2.46 359 36 
Ala-PEA 18.9 2.96 362 34 
 
 
 
 
 
 
 
 
Figure 2.1. Overlay of SEC traces of the two different PEAs in comparison to 2000 g/mol PEG.  
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The chemical structures of the two synthesized PEAs were confirmed by 1H NMR, 13C NMR 
and FT-IR spectroscopic methods. The 1H NMR data were in agreement with the anticipated 
chemical structures of the PEAs (Figure 2.2). Both spectra contained the -NH- peaks from the 
amide bonds generated by monomer 2 with monomer 1 and/or macromonomer 3, which were 
observed at ~8.80 and ~8.45 ppm, respectively. The spectra also had the =CH- peak at 6.84 ppm 
corresponding to the fumaric acid component (monomer 2). The spectrum of Ala-PEA differed 
from that of Phe-PEA due to the absence of aromatic proton peaks from 7.30 to 7.19 ppm, and 
the peaks of -CH2- adjacent to the phenyl ring from 3.07 to 2.89 ppm, as well as the upfield shift 
of peak 6 because of the difference in the structure of the amino acid. Moreover, each spectrum 
contained the characteristic peaks corresponding to the type of monomer 1 that was used, and 
they all had the PEG peaks, indicating the incorporation of macromonomer 3 into the overall 
PEA structures. Combined, the integrations of the peaks corresponded closely to the specific 
molar ratio of monomer 1:2:3 at 0.3:1.0:0.7 (Figures A7 and A9). The 13C NMR spectra further 
confirmed the structures of the PEAs as they contained all the expected peaks (Figures A10 and 
A12).    
  
 
 
 
 
 
 
 
 
Figure 2.2. 1H NMR spectra of a) Phe-PEA and b) Ala-PEA in DMSO-d6 (400 MHz).  
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The IR spectral data was also consistent with the successful formation of PEAs using the 
optimized polycondensation conditions (Figure 2.3). The two spectra had the same characteristic 
peaks corresponding to the amide N-H stretch at 3300 cm-1, the ester C=O stretch at 1740 cm-1, 
the amide C=O stretch at 1640 cm-1, and the amide N-H bend at 1550 cm-1. Additionally, they all 
had a broad peak near the region of ~3500 cm-1 corresponding to an amine N-H stretch, and a 
strong peak at 2880 cm-1 corresponding to alkane C-H stretches deriving from the PEG 
component (macromonomer 3) of PEAs as well as other C-H bonds on the other monomers. The 
presence of amine N-H stretching indicated that some polymers have amine termini. 
Furthermore, they all had a small peak around 3070 cm-1 corresponding to the alkene =C-H 
stretch from monomer 2. However, the C=C stretch peak in the region of 1620-1680 cm-1 was 
not visible as it likely overlapped with the carbonyl peaks. Although, IR spectroscopy was 
unable to fully confirm the presence of the double bond from monomer 2, it was strongly evident 
in the NMR spectra.   
  
 
 
 
 
 
 
 
 
Figure 2.3. FT-IR spectra of a) Phe-PEA and b) Ala-PEA. 
To assess the thermal properties of the PEAs, they were subjected to both TGA and DSC 
analyses (Table 2.1). Both PEAs had onset degradation temperatures (To) near 360 °C 
47 
 
(Figure 2.4). Based on the DSC results, it was clear that the PEAs were predominantly in 
crystalline rather than amorphous states due to the presence of melting peaks in both traces 
(Figure 2.5). Their glass transition temperatures (Tg) may be detected below -40 °C, however this 
was limited by the instrument. They had melting temperatures (Tm) that only differed by 2 °C as 
they were 36 °C and 34 °C for Phe-PEA and Ala-PEA respectively. The reason why the PEAs 
are highly crystalline could be due to the presence of the PEG component which is highly 
crystalline.40 Overall, Phe-PEA and Ala-PEA shared similar thermal properties despite their 
differences in the length of the diol component and the type of amino acid. 
  
 
 
 
 
 
Figure 2.4. TGA traces of Phe-PEA and Ala-PEA.   
  
 
 
 
 
 
Figure 2.5. DSC traces of a) Phe-PEA and b) Ala-PEA.    
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2.3.3 Fabrication and Characterization of PEA-based Hydrogels 
After the successful synthesis of water soluble, unsaturated polymers Phe-PEA and Ala-PEA, 
they were then tested to determine if they were capable of gelation. Crosslinkers including PEG-
dimethacrylate (PEGDMA) or methacrylated chondroitin sulphate (MCS), which are commonly 
used for hydrogel formation, were also incorporated in the formulations to aid the crosslinking of 
PEAs and to tune the properties of the resulting hydrogels (Figure 2.6).34,35 Both PEGDMA and 
MCS were synthesized based on procedures previously reported and they were characterized by 
1H NMR spectroscopy (Figures A14 and A15).34,35 Therefore, a series of hybrid hydrogels from 
Phe-PEA/Ala-PEA and PEGDMA/MCS precursors were investigated.  
  
 
 
 
Figure 2.6. Chemical structures of a) PEGDMA and b) MCS.  
The scaffold fabrication involved Irgacure 2959 as the photoinitiator at a concentration of 0.15% 
(m/v), PEGDMA or MCS at a concentration of 0 or 2.5% (m/v), and PEAs at a concentration of 
7.5 or 10% (m/v). Upon gelation, it was found that the hybrid hydrogels containing PEGDMA or 
MCS were very brittle, as their network structures fractured when pressure was applied to 
remove them from the syringe mold (Figure 2.7). However, the two pure PEA systems produced 
uniform gels suitable for the measurement of mechanical properties and ASC encapsulation. For 
this reason, these two systems were selected for the incorporation of DAT particles, to 
investigate the potential effects of ECM composition on the ASC response within the PEAs 
systems. DAT was added to the pure Phe-PEA and Ala-PEA formulations at 2% (m/v) as larger 
percentages led to disruption of the crosslinking. 
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Figure 2.7. Representative images of a series of hydrogel systems: a) Phe-PEA, b) Phe-PEA + 
PEGDMA, c) Phe-PEA + MCS, d) Ala-PEA, e) Ala-PEA + PEGDMA and f) Ala-PEA + MCS. 
Scale: 5 mm  
All of the hydrogel groups (pure PEAs, PEAs + PEGDMA/MCS/DAT) were characterized by 
the measurement of gel content, EWC and mass swelling ratio.  Gel content is the mass 
percentage of material successfully incorporated into the network, while EWC expresses the 
swelling degree of the crosslinked network with water relative to the dry weight of gel. For gel 
content, there was a common trend that all Phe-PEA-based systems had a greater gel content 
than the Ala-PEA-based systems (Figure 2.8a). However, the difference was only statistically 
significant for the systems with PEGDMA. Additionally, incorporating DAT did not have a 
noticeable effect on the gel content. The gel content was also similar when MCS was added. 
Meanwhile, the Ala-PEA hydrogels had consistently higher EWC than the Phe-PEA hydrogels, 
although the differences were only statistically significant when DAT was incorporated 
(Figure 2.8b). The higher EWC may be attributed to the difference in the amino acid monomers 
between the two polymers. Although the Ala monomer 1c has a longer aliphatic diol chain than 
the Phe monomer 1a, methyl side chains on Ala are much less hydrophobic than the phenyl side 
chains of Phe. However, it may also relate to the lower gel content for the Ala-PEA hydrogels, 
which likely correlates with a lower density of crosslinking. Overall, the hydrogels with 
PEGDMA and MCS incorporated had similar EWC to the pure PEA and PEA + DAT systems. 
As expected, the mass swelling ratios across the groups shared a similar trend to their EWC. Ala-
PEA-based systems swelled more than the Phe-PEA-based systems, though the difference was 
only statistically significant in the case of the hydrogels with DAT incorporated (Figure 2.8c). 
Additionally, it was found that the PEA hydrogels containing MCS swelled more than the other 
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groups. This increased degree of swelling can be attributed to the presence of charges on the 
MCS, which results in an influx of water through osmosis.     
  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.8. (a) Gel content of the hydrogels (n=3). *denotes a statistically significant difference 
between Phe-PEA + PEGDMA and Ala-PEA + PEGDMA. (b) Equilibrium water content of the 
hydrogels (n=3). *denotes a statistically significant difference between Phe-PEA + DAT and Ala-
PEA + DAT. c) Mass swelling ratio of the hydrogels (n=3). *denotes a statistically significant 
difference between Phe-PEA + DAT and Ala-PEA + DAT. Data was analyzed by one-way 
ANOVA with a Tukey’s post-hoc comparison of the means (p < 0.05).   
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Compressive moduli were only measured for the pure Phe-PEA and Ala-PEA hydrogels with 
and without 2% DAT, as the hydrogels with PEGDMA or MCS incorporated could not be 
measured due to their brittleness and poor structural integrity. Higher compressive moduli were 
obtained for Phe-PEA-based systems in comparison to the Ala-PEA-based systems both with and 
without DAT incorporated (Figure 2.9). The higher moduli for the Phe-PEA hydrogels may 
result from their trend towards lower EWC and swelling relative to the Ala-PEA systems, as this 
would result in a higher density of polymer in the network, leading to higher stiffness. 
Hydrophobic interactions between the phenyl group in the Phe domains, may also impart higher 
stiffness. Specifically, the modulus of the pure Phe-PEA system was significantly higher than 
that of the other three systems. Moreover, for both Phe-PEA and Ala-PEA, the incorporation of 
DAT reduced the compressive moduli, and a significant difference was observed between pure 
Ala-PEA hydrogels and Ala-PEA + DAT hydrogels. Although the systems with and without 
DAT had very similar gel contents, this result suggested that the incorporation of DAT may have 
introduced defects or inhomogeneities into the networks.  
  
 
 
 
 
Figure 2.9. Compressive moduli of pure PEAs and PEAs + DAT systems (n = 3). *denotes a 
statistically significant difference between Ala-PEA and Ala-PEA + DAT. **denotes that Phe-
PEA was statistically different than all other groups. Data was analyzed by one-way ANOVA 
with a Tukey’s post-hoc comparison of the means (p < 0.05).   
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2.3.4 Cell Viability  
The viability of ASCs encapsulated in the four different hydrogel systems (Phe-PEA and Ala-
PEA with and without 2% DAT) was assessed at 24 h post-encapsulation, as well as at 7 days 
after adipogenic induction (Figure 2.10a). Representative images of the hydrogels containing 
ASCs 24 h post encapsulation, where live cells appear green and dead cells appear red, are 
displayed in Figure 2.11. Large red-labeled structures were observed in hydrogel systems with 
DAT incorporated. Based on a cell-free control (Figure A16), we believe that these red structures 
result from the non-specific binding of the ethidium homodimer-1 stain to the DAT, and thus a 
size threshold was used for counting the average number of dead cells in each sample. At 24 h 
after encapsulation, all four hydrogel systems had viabilities higher than 75% with no significant 
differences observed between the systems. These results were in agreement with those of a 
previous study involving the encapsulation of ASCs into an MCS hydrogel system, and indicated 
that incorporating DAT did not influence the early cellular response.27 Overall, the viability 
results at 24 h suggested that both Phe-PEA-based and Ala-PEA-based systems provided a 
supportive environment for the encapsulated ASCs.  
While not statistically significant, from 24 h to 7 days, there was a trend towards decreasing 
viability across the groups and a slightly lower average number of viable cells per xy plane in the 
hydrogels (Figure 2.10b). It has been shown that cell density plays an important role in 
mediating adipogenic differentiation, as high cell density was found to be more favorable 
towards adipogenesis.28  Importantly, there were no significant differences in the average 
number of viable cells between the hydrogel groups at either time point, supporting that 
differences in cell density would not contribute to differences in ASC differentiation towards the 
adipogenic lineage in the later studies.  
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Figure 2.10. (a) ASC viability analysis of pure PEAs and PEAs + DAT systems at 24 h after 
encapsulation and at 7 days after induction of adipogenic differentiation (n = 3, N = 3), with no 
significant differences observed between the four hydrogel systems at either time point. 
(b) Average number of viable ASCs per xy plane within the pure PEAs and PEAs + DAT 
systems, with no significant differences observed at either time point. 
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Figure 2.11. Representative images of ASCs encapsulated in Phe-PEA, Phe-PEA + DAT, Ala-
PEA and Ala-PEA + DAT hydrogel systems at 24 h, displaying the distribution of live (green; 
calcein-AM) cells and dead (red; ethidium homodimer-1) cells along with DAT particles (blue 
due to autofluorescence): a) macroscopic view. Scale: 500 µm and b) microscopic view. 
Scale: 100 µm 
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2.3.5 Glycerol-3-phosphate Dehydrogenase (GPDH) Activity 
Quantitative analysis of adipogenesis within the pure PEAs and PEAs + DAT systems was 
assessed by evaluating the GPDH enzyme activities in the encapsulated ASCs at 7 days after 
adipogenic induction (Figure 2.12). Due to cell donor variability, the data acquired from each 
donor is presented separately for each hydrogel system. Based on the data, there were no 
significant differences found in the GPDH activity levels between the hydrogels fabricated with 
Phe-PEA-based versus Ala-PEA-based systems, indicating that all of the groups similarly 
supported adipogenic differentiation of the encapsulated ASCs. Additionally, when considering 
the mechanical properties of these four hydrogel systems, their compressive moduli (20-110 kPa) 
are greater than that of the native adipose tissue which is approximately 1-4 kPa.41 Although it 
would be predicted to be favorable for the scaffolds to match the modulus of the native tissues, a 
previous study demonstrated that MCS hydrogel systems with compressive moduli ranging from 
40 to 80 kPa were able to support ASC adipogenesis.27 The same study also demonstrated the 
inductive effect of DAT in promoting adipogenic differentiation by using 5 wt% of DAT.27 Their 
observation was consistent with other reported studies that investigated the potential of adipose 
tissue ECM in directing tissue-specific differentiation of ASCs.26,29,42 Based on the literature, we 
also expected to observe that incorporating the DAT in the PEA systems would have a positive 
effect in terms of adipogenesis, as stated in the hypothesis. However, no significant differences 
were shown with the DAT incorporated in both the Phe-PEA and Ala-PEA systems, which could 
be attributed to the limitation of this polymer system that was only able to incorporate 2 wt% of 
DAT while maintaining the stability of the hydrogel. This amount of DAT might be too little to 
induce an effect in adipogenic differentiation of ASCs as compared to the amount incorporated 
into the MCS in the previous study.27  
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Figure 2.12. GPDH activity of Phe-PEA, Phe-PEA + DAT, Ala-PEA and Ala-PEA + DAT 
hydrogel systems at 7 days after induction of adipogenic differentiation (n = 3, N = 3), with data 
showing responses from all three donors for each hydrogel system. The mean value for each 
group was represented by a bar. No significant differences were observed between the four 
hydrogel systems.  
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2.3.6 BODIPY Staining of Intracellular Lipid Accumulation  
Intracellular lipid accumulation in the pure PEAs and PEAs + DAT systems was visualized by 
using a BODIPY stain at 7 days after adipogenic induction (Figure 2.13). Adipogenesis was 
observed in all four hydrogel systems, as rounded green lipid droplets were detected by confocal 
microscopy. Similar to the quantitative GPDH analysis, the collected qualitative images 
suggested that all of the groups similarly supported the encapsulated ASCs differentiating into 
adipocytes, though a slightly higher number of lipid droplets was observed in the pure Phe-PEA 
system qualitatively. Notably, the lipid droplets were formed in close proximity to the DAT in 
both DAT incorporated systems. This was also observed in other studies, with clusters of 
differentiating ASCs containing lipid droplets found around the DAT.27,28 However, the 
incorporation of DAT within both PEA systems did not have a positive effect on the quantitative 
and qualitative markers of ASC adipogenesis in this study. Again, the lack of significant effects 
of the DAT may be attributed to the fact that only a low amount of DAT (2 wt%) could be 
incorporated within the PEAs while ensuring stable hydrogel formation. The previously-reported 
study utilized 3 and 5 wt% of DAT in the MCS hydrogel system, but significant differences in 
adipogenic differentiation were only observed for the 5 wt% formulation both quantitatively and 
qualitatively.27  Therefore, 2 wt% of DAT incorporated in the PEA systems might not be 
sufficient to promote adipogenic differentiation of the encapsulated ASCs.   
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Figure 2.13. Representative images of BODIPY-stained (green) intracellular lipid droplets in 
ASCs from three different donors, encapsulated in Phe-PEA, Phe-PEA + DAT, Ala-PEA and 
Ala-PEA + DAT hydrogel systems at 7 days after induction of adipogenic differentiation. 
Qualitatively more intracellular lipid droplets were observed for the pure Phe-PEA system. In the 
composites incorporating the DAT, the cells containing lipid droplets were generally found 
around the DAT particles (blue due to autofluorescence). Scale: 50 µm     
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2.4 Conclusions  
New water soluble PEAs with crosslinkable moieties were successfully synthesized from a 
phenylalanine-based monomer, alanine-based monomer, p-nitrophenyl fumarate and a PEG 
diamine. The PEAs were only water soluble when a 70:30 PEG:amino acid monomer ratio was 
used and for Phe-PEA and Ala-PEA. A series of hydrogels were fabricated from the two PEAs 
including sample groups incorporating PEGDMA, MCS and DAT particles. Phe-PEA-based 
systems had a trend towards greater gel contents, lower swelling and higher compressive moduli 
when compared to the Ala-PEA-based systems, potentially due to the phenyl group of Phe-PEA 
being more hydrophobic than the methyl group of Ala-PEA though statistically significant 
differences between the two polymers were only observed for selected examples. ASC viability 
and adipogenesis were investigated in the Phe-PEA and Ala-PEA systems both with and without 
DAT incorporation. Similar viabilities were observed for both PEA systems, indicating that these 
new PEAs both provided a supportive environment for ASCs. Adipogenic differentiation was 
assessed in the two different PEA systems both quantitatively and qualitatively by measuring 
GPDH enzyme activity and staining for intracellular lipid accumulation, respectively. All of the 
groups were observed to similarly support ASC adipogenesis. Overall, this study demonstrated 
the potential of these new water soluble PEAs as biomaterials for adipose tissue engineering. 
Future work will focus on measuring adipogenic gene expression to further quantify 
adipogenesis within the PEA systems, running a time course study for assessing adipogenic 
differentiation of ASCs as 7 days is not long enough to observe a mature phenotype, and 
optimizing the hydrogel formulation to increase the amount of DAT incorporated.  
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Chapter 3  
3 Conclusions and Future Work  
Overall, this thesis presented the synthesis of new water soluble, amino acid-based PEAs with 
crosslinkable moieties for hydrogel fabrication and explored their potential as biomaterials for 
adipose tissue engineering. The water solubility of the polymers was achieved by carefully 
controlling the molar ratio of PEG and amino acid monomers. Moreover, the resulting Phe-PEA 
and Ala-PEA polymers could be reproducibly synthesized with an Mn of approximately 
20 kg/mol and Đ of 2-3 through a tailored reaction condition. Using the double bond 
incorporated into the PEA backbone, the polymers could be crosslinked photochemically to form 
stable hydrogels. The properties of these PEA-based hydrogels could be tuned by the addition of 
other components including PEGDMA, MCS and DAT particles. However, based on the 
structural uniformity of the hydrogels, formulations containing only the PEAs as well as PEAs 
with DAT particles were most promising and were therefore selected for the measurement of 
mechanical properties and for ASC encapsulation. The viability and adipogenic differentiation of 
ASCs from three different human donors were studied in Phe-PEA and Ala-PEA hydrogels with 
and without DAT. Overall, the results demonstrated that these new PEA hydrogels supported the 
viability of ASCs and their differentiation towards the adipogenic lineage, and given their 
property tunability and potential to be biodegradable, these PEAs are promising candidates for 
adipose tissue engineering.  
There are a few aspects that can be addressed in terms of the future work for this project. First, 
DAT has been demonstrated to exhibit tissue-specific instructive effects in promoting ASC 
adipogenic differentiation.1–4 However, the amount of DAT (2 wt%) that could be stably 
incorporated into the PEA systems studied in this project was quite low compared to the previous 
study that used 5 wt% DAT within MCS hydrogels to produce significant effects on adipogenic 
differentiation.1 Therefore, it would be advantageous to optimize the hydrogel formulation to 
enable the incorporation of higher amounts of DAT. Several approaches can be explored, such as 
using a different crosslinking method that may allow more DAT to be incorporated into PEA 
hydrogels. Thermally initiated crosslinking using ammonium persulphate (APS) and 
tetramethylethylenediamine (TEMED) may be a good alternative method as it has been used in 
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our lab to generate a composite hydrogel containing MCS and DAT.5 In addition, decreasing the 
concentration of PEA to 8 wt% may lead to a less viscous solution and allow more DAT to be 
added by improving dispersion in the prepolymer solution. Secondly, to be able to more fully 
analyze the ASC adipogenic response, negative controls of the various hydrogel groups should 
be included in the study with scaffolds maintained in proliferation medium for 7 days to assess 
possible inductive effects of the DAT and/or 3-D culture conditions. In addition, performing 
real-time reverse transcription polymerase chain reaction (RT-qPCR) analysis of adipogenic 
gene expression (e.g. PPARg and LPL) would be beneficial to further quantify ASC adipogenic 
differentiation within these PEA systems. Furthermore, running a time course study that extends 
to 14 or 21 days to allow for the formation of more mature adipocytes would be valuable to 
evaluate these PEA systems as long-term delivery vehicles for ASCs for adipose tissue 
engineering applications. Finally, as the results in this thesis demonstrated that these new PEAs 
overall provided a supportive environment for ASCs, it would be interesting to explore their 
capacity to support ASC differentiation towards the chondrogenic and osteogenic lineages, 
including within composites incorporating decellularized ECM from cartilage and bone.       
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Appendix 1: Supplementary Figures 
 
 
 
 
 
 
 
 
 
 
Figure A1. 1H NMR spectrum of monomer 1a in DMSO-d6 (600 MHz).  
 
 
 
 
 
 
 
68 
 
 
 
 
 
 
 
 
 
 
Figure A2. 1H NMR spectrum of monomer 1b in DMSO-d6 (600 MHz). 
 
 
 
 
 
 
 
 
 
Figure A3. 1H NMR spectrum of monomer 1c in DMSO-d6 (600 MHz). 
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Figure A4. 1H NMR spectrum of monomer 2 in DMSO-d6 (600 MHz). 
   
 
 
 
 
 
 
 
Figure A5. 1H NMR spectrum of PEG ditosylate, reaction intermediate of macromonomer 3 in 
CDCl3 (600 MHz). 
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Figure A6. 1H NMR spectrum of macromonomer 3 in CDCl3 (600 MHz). 
  
 
 
 
 
 
 
 
 
Figure A7. 1H NMR spectrum of Phe-PEA in DMSO-d6 (400 MHz).  
71 
 
  
 
 
 
 
 
 
 
 
Figure A8. 1H NMR spectrum of Phe8-PEA in DMSO-d6 (400 MHz). 
 
 
 
 
 
 
 
 
 
Figure A9. 1H NMR spectrum of Ala-PEA in DMSO-d6 (400 MHz). 
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 Figure A10. 13C {1H} NMR spectrum of Phe-PEA in DMSO-d6 (100 MHz). 
 
 
 
 
 
 
 
 
 
Figure A11. 13C {1H} NMR spectrum of Phe8-PEA in DMSO-d6 (100 MHz). 
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Figure A12. 13C {1H} NMR spectrum of Ala-PEA in DMSO-d6 (100 MHz). 
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Figure A13. Characterizations of Phe8-PEA: a) SEC trace, b) FT-IR spectrum, c) TGA trace and 
d) DSC trace.     
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Figure A14. 1H NMR spectrum of PEGDMA in CDCl3 (600 MHz).  
 
    
 
 
 
 
 
 
 
Figure A15. 1H NMR spectrum of MCS in D2O (600 MHz). 
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Figure A16. Representative images of the overlapping between large aggregates of dead cell and 
DAT signals in a cell-free control sample, Ala-PEA + DAT. Scale: 100 µm 
 
Table A1. Summary of cell donor information for all biological studies. 
Type of Biological Studies Donor Information 
Cell Viability 
Donor 1: 33 yr, BMI = 24.5 
Donor 2: 47 yr, BMI = 26.8 
Donor 3: 54 yr, BMI = 25.2 
GPDH/BODIPY Staining 
Donor 1: 52 yr, BMI = 37.9 
Donor 2: 54 yr, BMI = 25.2 
Donor 3: 47 yr, BMI = 26.8 
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